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Abstract 9-Substituted phenanthrene-3-carboxylic acids have been
reported to have allosteric modulatory activity at the N-methyl-D-aspar-
tate (NMDA) receptor. This receptor is activated by the excitatory neu-
rotransmitter L-glutamate and has been implicated in a range of neuro-
logical disorders such as schizophrenia, epilepsy and chronic pain, and
in neurodegenerative disorders such as Alzheimer’s disease. Herein, the
convenient synthesis of a wide range of novel 3,9-disubstituted
phenanthrene derivatives starting from a few common intermediates is
described. These new phenanthrene derivatives will help to clarify the
structural requirements for allosteric modulation of the NMDA recep-
tor.
Key words phenanthrenes, NMDA receptor, allosteric modulators,
palladium coupling, Wittig reaction
Phenanthrene is a naturally occurring polycyclic aro-
matic ring system that is found in a number of biologically
active compounds.2 Recently, we reported that phenan-
threne derivatives such as 1, 2 and 3 (Figure 1) are allosteric
modulators of the N-methyl-D-aspartate (NMDA) family of
ionotropic glutamate receptors (i-GluRs).3 NMDA receptors
are tetrameric ligand-gated ion channels comprised of
GluN1 and GluN2A-D subunits.3 NMDA receptors have been
implicated in a range of neurological disorders such as epi-
lepsy, schizophrenia and chronic pain, and neurodegenera-
tive disorders such as ischaemia, Alzheimer’s disease and
Parkinson’s disease.3 Allosteric modulators have the poten-
tial to be used in the treatment of these disorders because
they are less likely to interfere with the physiological roles
of NMDA receptors compared with competitive antagonists
or channel blockers.3 A convenient synthetic route to 3-car-
boxy-phenanthrenes with a wide range of hydrophobic and
hydrophilic substituents at the 9-position was required to
conduct a structure-activity relationship (SAR) study on al-
losteric modulators 1–3.
Figure 1  NMDA receptor allosteric modulators
With the exception of the 9-bromo, 9-chloro and 9-car-
boxy derivatives, no 9-substituted 3-carboxyphenan-
threnes have previously been reported.4,5 Herein, we report
the synthesis of 1–3 and a novel series of their derivatives
starting from a few common intermediates.
Initial studies suggested that 9-iodophenanthrene-3-
carboxylic acid (1) had an interesting pharmacological pro-
file3 and so we investigated suitable methods for larger
scale production of this compound. We recently reported a
two-step route to 1 in which an aromatic Finkelstein reac-
tion6 was utilised to convert 3-acetyl-9-bromophenan-
threne (4) into its corresponding 9-iodo analogue 9
(Scheme 1).7 A haloform reaction was then employed to ox-
idise the acetyl group and give the desired acid. However,
although our initial experiments led to complete conver-
sion, subsequent attempts to synthesise 9 led only to insep-
arable mixtures of 4 and 9. Despite extensive investigation
HO2C
R
1 R = I
2 R = c-Pr
3 R = (CH2)3i-Pr
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(e.g., different amine ligands, alternative solvents, purifica-
tion of copper (I) iodide catalyst), no satisfactory reason for
the non-reproducibility of the aromatic Finkelstein reaction
could be established. With the halogen conversion route
proving unreliable, an alternative and more robust pathway
to 1 was sought. Unfortunately, attempts to iodinate the 9-
position of phenanthrene-3-carboxylic acid (5) directly us-
ing either iodine monochloride or sodium iodide and sodi-
um hypochlorite (Scheme 2) led only to the recovery of un-
reacted starting material. As a consequence, we decided to
focus on developing an alternative route to ketone 9. The
most obvious route to this compound is through Friedel–
Crafts acylation. However, whilst Friedel–Crafts acylation
can be used to synthesise the 3-acetyl derivatives of both 9-
bromo and 9-chlorophenanthrene, we found that employ-
ing the same reaction conditions on 9-iodophenanthrene
(6) led only to the isolation of a black tar (Scheme 2).4,5 At-
tempts to modify the reaction conditions by using alumini-
um iodide instead of aluminium chloride, or acetic anhy-
dride instead of acetyl chloride, led to the same outcome.
With all previous routes proving unsuccessful, we investi-
gated the use of lithiation as a possible way of introducing
the iodo substituent (Scheme 1). After protecting ketone 4
as the acetal 7, lithiation at the 9-position followed by
quenching with (n-Bu)3SnCl afforded stannane 8.
The 9-iodo group was then readily introduced by stir-
ring with a saturated solution of iodine in dichloromethane
at 0 °C. Subsequent deprotection gave ketone 9, which was
then easily converted into 1 by using the haloform reaction
described previously. In theory, the iodo group could have
been introduced by quenching the lithiated species with io-
dine. However, we were concerned that employing this
route would lead to the formation of side products that
could not be easily separated from the desired product. Al-
though it added an additional step, utilising stannane 8 al-
lowed 1 to be synthesised both cleanly and in high yield.
Scheme 1  Reagents and conditions: (a) NaI, CuI, N,N′-dimethylethylenediamine, dioxane, 110 °C, 65 h; (b) ethylene glycol, TsOH, toluene, 110 °C, 18 h; 
(c) i. n-BuLi, THF, –78 °C, 1 h, ii. (n-Bu)3SnCl, –78 °C; (d) i. I2, CH2Cl2, 0 °C, ii. 2 M HCl (aq), acetone, 0.5 h; (e) i. Br2, NaOH (aq), dioxane, 70 °C, 1 h; 
ii. concd HCl (aq); (f) i. n-BuLi, THF, –78°C, 1 h; ii. MeSSMe, –78 °C then r.t.; (g) HCl–acetone, 1 h, r.t.; (h) i. Br2, NaOH, dioxane, 40 °C, 1 h; ii. concd HCl.
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Scheme 2  Reagents and conditions: (a) ICl, AcOH, 118 °C, 18 h; (b) NaI, 
NaClO, NaOH, MeOH, 0 °C then r.t., 1 h; (c) AcCl, AlCl3, CS2, 5 °C then 
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Scheme 3  Reagents and conditions: Part A (a) i. Methyl acrylate, (o-tolyl)3P, Et3N, Pd(OAc)2, DMF, 100 °C, 18 h, ii. MeI, K2CO3, DMF, r.t., 18 h; (b) i. OsO4, 
TMAO, t-BuOH/H2O, r.t., 2 d; ii. NaIO4; (c) MeOH, H2SO4, reflux, 48 h. Part B (a) RCH2PPh3X, KHMDS, THF, 4 h, r.t.; (b) alkene, (o-tolyl)3P, Et3N, Pd(OAc)2, 
DMF, 100 °C, 18 h; (c) (n-Bu)3SnCH=CH2, Pd(PPh3)4, toluene, reflux, 4 h; (d) H2, 10% Pd/C, EtOAc, r.t., 18 h; (e) i. NaOH or KOH (aq), THF, reflux or diox-
ane, 75 °C; ii. 1 M HCl (aq); (f) 17a, CH2I2, Et2Zn, CH2Cl2, 0 °C, 18 h; (g) i. LiOH (aq), dioxane, r.t., 18 h; ii. 1 M HCl (aq); (h) 3-thienylboronic acid, K2CO3, 
Pd(dppf)Cl2·CH2Cl2, DME, 80 °C, 24 h; (i) i. NaOH (aq), dioxane, 75 °C; ii. 1 M HCl (aq); iii. crystallisation (AcOH).
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Our attention then turned to the synthesis of a structur-
ally diverse series of 3-carboxyphenanthrenes bearing hy-
drophobic substituents at the 9-position as analogues of
compounds 1–3. Amongst the initial group of compounds
generated was thioether 12, which was synthesised by us-
ing an identical strategy to that described for 1 with the ex-
ception that after being lithiated, acetal 7 was quenched
with dimethyl disulfide (Scheme 1). Deprotection subse-
quently afforded acetyl 11, which was then readily convert-
ed into carboxylic acid 12 by using the haloform reaction.
In addition to thioethers, compounds bearing alkyl sub-
stituents at the 9-position were synthesised. Initial at-
tempts to generate these derivatives by reacting alkyl alde-
hydes with lithiated acetal 7 gave only a complex mixture
of products. Consequently, an alternative route was devised
to allow a range of alkyl chains to be introduced using com-
mon intermediates, which could be prepared both quickly
and in high yield. With this in mind, the 9-formyl (15) and
9-bromo (16) substituted phenanthrenes were chosen be-
cause both functional groups could be easily manipulated
by using either Wittig or palladium coupling chemistry to
afford a large variety of 9-alkylphenanthrenes from com-
mercially available reagents. Both 15 and 16 were conve-
niently prepared from 9-bromo acid 13 (Scheme 3, A).7
Heck coupling of 13 with methyl acrylate followed by ester-
ification with methyl iodide afforded diester 14. Oxidation
of alkene 14 with osmium tetroxide and cleavage of the re-
sultant 1,2-diol with sodium periodate afforded 9-formyl
derivative 15. Methyl ester 16 was generated in good yield
by Fisher esterification of acid 13.4
Conducting either Wittig or Heck chemistry on 15 and
16 proceeded smoothly and led to the synthesis of alkene
intermediates 17a–i, which, in the majority of cases, were
hydrogenated immediately to their corresponding alkyl
counterparts 18a–i (Scheme 3, B). Base-mediated hydroly-
sis subsequently afforded the desired 9-alkyl-3-carboxy-
phenanthrenes (3, 19a–d, 19f–h, and 19j). The 9-cyclopro-
pyl derivative 2 was synthesised from vinyl 17a in two
steps. First, the cyclopropyl ring was formed through a
Simmons–Smith reaction to give 20. Base-mediated hydro-
lysis of the ester subsequently afforded the desired acid 2.
Initially, alkene 17a was prepared from 15 through Wittig
chemistry. Although this route proved to be successful, we
found that the compound was more conveniently prepared
through Stille coupling between 16 and (tri-n-butyl)vinyl
tin (Scheme 3, B).
To investigate the introduction of a heteroaromatic moi-
ety, Suzuki coupling was employed to react 16 and 3-thie-
nyl boronic acid (Scheme 3, B). Unfortunately, this reaction
did not go to completion and led to the isolation of a mix-
ture of product 21 and starting material 16 (ca. 75:25 ratio
based on 1H NMR spectroscopic analysis). Despite an inves-
tigation of different solvent systems, it was not possible to
separate the individual esters by silica gel chromatography.
Consequently, the mixture was taken forward and hydro-
lysed by using a base. By conducting multiple recrystallisa-
tions from glacial acetic acid, we were able to separate the
mixture of acids and obtain a pure sample of 22 (Scheme 3,
B).
Scheme 4  Reagents and conditions: (a) CuI, NaI, MeMgCl, TMSCl, CH2Cl2/Me2S, –78 °C then r.t., 3 h; (b) KHMDS, THF, 2-tosyl-3-phenyloxaziridine, 
–78 °C then r.t., 2 h; (c) i. LiBH4, THF, 0 °C, 30 min then r.t., 4 h; ii. t-BuOH–H2O (4:1), NaIO4, r.t., 30 min; (d) NaBH4, THF, r.t., 4 h; (e) i. MsCl, Et3N, 0 °C, 
1 h then r.t., 3 h; ii. NaI, acetone, reflux, 24 h; iii. H2, Et3N, 10% Pd/C, r.t., 18 h; (f) i. NaOH (aq), dioxane, 75 °C; ii. 1 M HCl (aq).
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Synthesis of the branched 9-isopropyl derivative 30 re-
quired a different strategy to that described above (Scheme
4). This strategy had the added advantage of generating two
intermediates (24 and 28) that could be pharmacologically
characterised. Starting from diester 14, 1,4-conjugate addi-
tion of methyl magnesium chloride afforded 23 in reason-
able yield. Whilst a small amount of this compound was hy-
drolysed with base to diacid 24, the majority was reacted
with 2-tosyl-3-phenyloxaziridine8 to generate alcohol 25
(Scheme 4). Reduction of the alkyl ester with lithium boro-
hydride and cleavage of the resultant 1,2-diol with sodium
periodate, led to the synthesis of aldehyde 26.
Reduction of the aldehyde with sodium borohydride
gave alcohol 27 in good yield. A small amount of this ester
was hydrolysed to the corresponding acid 28 by using a
base (Scheme 4). Alcohol 27 was then converted into the
corresponding mesylate by reaction with methanesulfonyl
chloride. The mesylate was, in turn, converted into the cor-
responding iodo derivative through a Finkelstein reaction.
Subsequent hydrogenation led to dehalogenation and yield-
ed the 9-isopropyl derivative 29, which was readily hydro-
lysed to the desired acid 30 (Scheme 4).
In addition to its use in the previously described Wittig
chemistry, aldehyde 15 was utilised as a starting point for
the synthesis of 9-methyl derivative 35 (Scheme 5). Reduc-
tion of the aldehyde by using sodium borohydride afforded
9-hydroxymethyl derivative 31. A small portion of this
compound was hydrolysed to yield acid 32 for pharmaco-
logical characterisation, whereas the majority was taken
forward and reacted with phosphorus tribromide to afford
9-bromomethyl 33. Hydrogenation subsequently afforded
9-methyl derivative 34, which was readily hydrolysed to
the corresponding acid 35 (Scheme 5).
Although the introduction of hydrophobic substituents
was our primary focus, we wanted to synthesise some com-
pounds with more polar groups at the 9-position to gather
additional data on the requirements for biological activity.
For example, aldehyde 15 was reacted with isopropylamine
through reductive amination to afford ester 36, which was
subsequently hydrolysed to acid 37 (Scheme 5). Similarly,
alkene 14 was hydrogenated to afford alkyl diester 38,
which was then hydrolysed to diacid 39 (Scheme 6).
Scheme 6  Reagents and conditions: (a) H2, 10% Pd/C, EtOAc, r.t., 18 h; 
(b) i. NaOH (aq), THF, reflux, 4 h; ii. 1 M HCl (aq).
To identify the optimal 3-position substituent for bio-
logical activity, the 3-carboxy group in 1 was subjected to
chemical modification (Scheme 7). Interestingly, attempts
to reduce this moiety by using lithium aluminium hydride
led not only to reduction of the desired group but also to
dehalogenation. Consequently, a pathway was devised in
which the acid chloride of 1 was generated through reac-
Scheme 5  Reagents and conditions: (a) NaBH4, THF, r.t., 4 h; (b) Br3P, CH2Cl2, 0 °C then r.t., 2 h; (c) H2, 10% Pd/C, r.t., 18 h; (d) i. NaOH (aq), dioxane, 
75 °C, ii. 1 M HCl (aq); (e) i-PrNH2, NaBH(OAc)3, DCE, r.t., 40 h; (f) i. NaOH (aq), dioxane, 75 °C, 4 h; ii. 1 M HCl (aq); iii. ion-exchange chromatography.
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tion with thionyl chloride and then reduced under mild
conditions using sodium borohydride (Scheme 7). This
route was successful and led to the synthesis of 3-hy-
droxymethyl 40 in good yield. Reaction of 40 with phos-
phorus tribromide afforded 3-bromomethyl 41, which was,
in turn, converted into the corresponding nitrile 42 by reac-
tion with sodium cyanide under phase-transfer conditions.
Hydrolysis of the nitrile under acidic conditions gave 3-ace-
tic acid derivative 43 (Scheme 7).9
Scheme 7  Reagents and conditions: (a) i. SOCl2, dioxane, reflux, 12 h; 
ii. NaBH4, THF, 0 °C, 0.5 h, then r.t., 12 h; (b) Br3P, CH2Cl2, 0 °C then r.t., 
1 h; (c) NaCN, TBAB, H2O/CH2Cl2 (1:1), r.t., 5 d; (d) AcOH, H2SO4, H2O, 
118 °C, 3 h.
In a further modification to the 3-position, the acid
chloride of 1 was reacted with benzylamine, phenethyl-
amine and the tert-butyl ester of glycine to afford amides
44a, 44b and 45 (Scheme 8). Deprotection of the tert-butyl
ester to afford acid 46 was achieved readily and in good
yield by reaction with TFA (Scheme 8).
A previously described electrophysiological assay on
GluN1 and GluN2A-D subunits individually expressed in
Xenopus oocytes3 was used to pharmacologically charac-
terise a selection of the synthesised phenanthrenes. The
compounds were tested at a concentration of 100 μM for
their effects on GluN1/GluN2A-D receptor responses and
percentage antagonism or potentiation of responses to glu-
tamate (10 μM) and glycine (10 μM) was determined (Table
1). Although only preliminary, these data suggest that:
I
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a
X
X = OH
X = Br
X = CN
X = CO2H
b
c
d
40
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43
Scheme 8  Reagents and conditions: (a) SOCl2, benzene, 80 °C, 12 h; (b) RNH2, Et3N, dioxane, r.t., 3 h; (c) H-Gly-OtBu·HCl, Et3N, dioxane, r.t., 3 h; 
(d) TFA, CH2Cl2, r.t., 18 h.
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Table 1  Activity of Selected 3,9-Disubstituted Phenanthrene Deriva-
tives at Recombinant NMDA Receptor Subtypesa
NMDAR (n≥4)b
Compoundc GluN2A GluN2B GluN2C GluN2D
 1   8.6 ± 4.8   0.9 ± 0.1 –34.1 ± 8.3 –52.3 ± 3.0
 2  36.0 ± 7.4  51.2 ± 13.2  –7.3 ± 0.4   5.6 ± 4.7
 3  31.5 ± 10.0  34.0 ± 8.5  21.8 ± 8.1  24.3 ± 3.6
35  –4.8 ± 4.6  –3.2 ± 0.3 –15.1 ± 0.3  –4.1 ± 0.9
19b   6.6 ± 1.2  30.0 ± 1.8   5.2 ± 4.0   7.8 ± 1.8
19d   42.6 ± 9.6  42.1 ± 14.3  26.4 ± 5.4d  20.3 ± 5.3
19f  28.2 ± 11.4  20.5 ± 7.5  19.6 ± 3.0  24.6 ± 7.3
22  10.7 ± 6.4   3.9 ± 12.6 –52.7 ± 9.1 –45.2 ± 8.7
37 –21.9 ± 9.2  –0.3 ± 1.8 –13.0 ± 2.5  –2.6 ± 0.8
39 –48.1 ± 6.5 –51.1 ± 3.4 –17.8 ± 2.7 –15.1 ± 0.7
43 –23.5 ± 3.9 –30.9 ± 3.8 –46.7 ± 4.3 –66.6 ± 4.1
a All compounds tested at a concentration of 100 μM.
b Percent inhibition (negative number) or potentiation (positive number) of 
the responses of recombinant rat NMDA receptors (GluN1 expressed with 
the indicated GluN2 subunit) expressed in Xenopus oocytes (mean ± 
s.e.m.).
c All of the compounds were made up as stocks solutions in DMSO and were 
soluble up to a concentration of 100 μM in the buffer used in these assays.
d 19d inhibited 22% in one experiment; this value was not included in the 
average shown.
1599
© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2015, 47, 1593–1610
M. W. Irvine et al. PaperSyn thesis
(a) an alkyl substituent at the 9-position promotes NMDA
receptor potentiating activity; (b) as the length and/or size
of the alkyl chain increases so does NMDA receptor potenti-
ation (compare activity of 35 vs. 2, 3, 19b, 19d and 19f);
(c) introduction of a polar group into the alkyl side chain
promotes NMDA receptor antagonism over potentiation (37
and 39); (d) the 9-iodo group can be replaced by a 3-thienyl
ring without adversely affecting activity (compare activity
of 1 vs. 22), and (e) moving the carboxyl group away from
the phenanthrene ring is beneficial for NMDA receptor an-
tagonism (compare activity of 1 vs. 43).
In conclusion, we have developed an alternative and ro-
bust synthetic pathway to 9-iodophenanthrene-3-carbox-
ylic acid (1), a novel allosteric NMDA receptor modulator.
Starting from a few common intermediates, we have syn-
thesised a series of novel phenanthrene derivatives with a
variety of substituents at the 3- and 9-positions of the
phenanthrene ring. It is hoped that these compounds will
lead to a better understanding of the structural require-
ments for allosteric modulation of the NMDA receptor. The
preliminary pharmacological data described here suggests
that the new compounds have interesting profiles of activi-
ty on NMDA receptor subtypes. Further pharmacological
characterisation of these newly synthesised compounds is
ongoing and will be reported in due course.
Reagents were purchased from commercial suppliers and purified by
standard techniques when necessary. All anhydrous solvents were
obtained from either Acros or Sigma–Aldrich and used without fur-
ther drying. All anhydrous reactions were conducted under an inert
atmosphere. Melting points were determined with an Electrothermal
IA9100 capillary apparatus and are uncorrected. 1H NMR spectra
were measured with either a Jeol spectrometer at 270.18 MHz, a Jeol
JNM-LA300 spectrometer at 300.53 MHz, a Jeol JNM-ECP400 spec-
trometer at 400.18 MHz, or a Varian 400MR spectrometer at 399.77
MHz. 13C NMR spectra were recorded with either a Jeol JNM-LA300
spectrometer at 75.57 MHz, a Jeol JNM-ECP400 spectrometer at
100.63 MHz, or a Varian 400MR spectrometer at 100.52 MHz. Chemi-
cal shifts (δ) are reported in parts per million (ppm) with 3-(trimeth-
ylsilyl)propionic-2,2,3,3-d4 acid sodium salt in D2O, or tetramethylsi-
lane in CDCl3 or DMSO-d6 used as internal standards. Mass spectrom-
etry was performed in the mass spectroscopy laboratories of the
Department of Chemistry, University of Bristol, UK. Elemental analy-
ses were performed in the microanalytical laboratories of the Depart-
ment of Chemistry, University of Bristol, UK. The purity of all novel
compounds was determined by combustion analysis, which con-
firmed that they were ≥95% pure. Thin-layer chromatography was
performed on Merck silica gel 60 F254 plastic sheets. Flash chromatog-
raphy was performed on Merck silica gel 60 (220–440 mesh) from
Fisher.
2-(9-Bromophenanthren-3-yl)-2-methyl[1,3]dioxolane (7)
A stirred solution of 44 (20.9 g, 70 mmol), ethylene glycol (8.68 g, 0.14
mol) and TsOH·H2O (0.67 g, 3.5 mmol) in toluene (200 mL) was heated
at reflux with a Dean–Stark trap in place overnight. After cooling to
r.t., the reaction mixture was washed with sat. aq NaHCO3 (50 mL)
and H2O (50 mL). The organic layer was isolated, dried over MgSO4
and concentrated in vacuo to approximately 50 mL. At this point, the
product precipitated out of solution as a white solid and was filtered
off. Further concentration of the mother liquor to approximately 10
mL led to the precipitation of a second crop of product, which was
again collected by filtration. The mother liquor was then concentrat-
ed in vacuo and the remaining residue was purified by flash chroma-
tography (EtOAc–hexane, 2%) to give 7.
Yield: 23.4 g (97%); white solid.
1H NMR (300 MHz, CDCl3): δ = 1.79 (s, 3 H), 3.79–3.90 (m, 2 H), 4.07–
4.18 (m, 2 H), 7.64–7.86 (m, 4 H), 8.10–8.23 (m, 1 H), 8.34–8.43 (m,
1 H), 8.69–8.79 (m, 2 H).
HRMS (CI): m/z [M + H]+ calcd for C18H15O2Br: 343.0334; found:
343.0338.
Tributyl-[3-(2-methyl[1,3]dioxolan-2-yl)phenanthren-9-yl]stan-
nane (8)
To a solution of 7 (22.2 g, 65 mmol) in anhydrous THF (350 mL) at
–78 °C was added carefully and dropwise a solution of n-BuLi (2.5 M
in hexane, 31 mL, 78 mmol). The resultant mixture was stirred for 1 h
at –78 °C, then the reaction was quenched with n-Bu3SnCl (23 mL,
84.5 mmol). After complete addition, the solution was warmed to r.t.,
the reaction mixture was diluted with Et2O (500 mL) and the organic
layer was isolated, washed with H2O (150 mL), dried over MgSO4 and
concentrated in vacuo. The resultant residue was purified by flash
chromatography (EtOAc–hexane, 2%) to afford 8 (31.9 g, 89%), which
was utilised in the next step without further analysis.
3-Acetyl-9-iodophenanthrene (9)
Compound 8 (31.9 g, 57.7 mmol) was dissolved in CH2Cl2 (150 mL)
and a saturated iodine solution in CH2Cl2 was added slowly at 0 °C un-
til the colour of the last drop of iodine did not disappear within 30 s.
The organic solution was then washed with sat. NaHSO3 (50 mL), H2O
(50 mL), dried over MgSO4, and concentrated in vacuo. The resultant
residue was dissolved in acetone (200 mL) and aq 2 M HCl (4 mL) was
added dropwise. The ketone precipitated out of solution almost im-
mediately and, after stirring for 30 min, 9 was collected by filtration.
Yield: 17.0 g (85%); white solid; mp 149–151 °C (Lit.7 148–150 °C).
1H NMR (300 MHz, CDCl3): δ = 2.78 (s, 3 H), 7.67–7.75 (m, 2 H), 7.78
(d, J = 8.4 Hz, 1 H), 8.10 (dd, J = 8.4, 1.8 Hz, 1 H), 8.20–8.24 (m, 1 H),
8.44 (s, 1 H), 8.66–8.71 (m, 1 H), 9.24 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 26.7, 102.4, 122.7, 123.8, 126.1, 127.9,
128.1, 128.4, 129.8, 130.7, 132.4, 133.5, 135.1, 135.3, 137.9, 197.8.
9-Iodophenanthrene-3-carboxylic Acid (1)
Synthesised from 9 as described previously.7
2-Methyl-2-(9-methylsulfanylphenanthren-3-yl)-[1,3]dioxolane 
(10)
To a stirring solution of 7 (1.72 g, 5.00 mmol) in anhydrous THF (50
mL) at –78 °C was added dropwise a solution of n-BuLi (2.5 M in
hexane, 2.4 mL, 6.00 mmol). After complete addition, the solution
was stirred for 1 h, then the reaction was quenched by the dropwise
addition of dimethyl disulfide (0.59 mL, 6.50 mmol). The mixture was
then warmed to r.t. before being diluted with Et2O (50 mL). The or-
ganic layer was isolated, washed with H2O (50 mL), dried over MgSO4
and concentrated in vacuo. The resulting residue was purified by flash
chromatography (EtOAc–hexane, 2%) to afford 10, which was utilised
in the next step without further analysis.
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1-[9-(Methylsulfanyl)phenanthren-3-yl]ethanone (11)
Concentrated HCl (0.4 mL) was added dropwise to a stirred solution
of 10 in acetone (100 mL). The resultant solution was stirred for 1 h,
during which a precipitate formed. This solid was filtered off and
washed with cold acetone (20 mL). Recrystallisation from acetone af-
forded 11.
Yield: 954 mg (72%); off-white solid; mp 135–137 °C.
1H NMR (400 MHz, CDCl3): δ = (s, 3 H), 2.78 (s, 3 H), 7.50 (s, 1 H),
7.67–7.78 (m, 2 H), 7.83 (d, J = 8.4 Hz, 1 H), 8.12 (dd, J = 8.4, 1.6 Hz,
1 H), 8.31–8.35 (m, 1 H), 8.77–8.81 (m, 1 H), 9.25 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 15.3, 26.9, 120.8, 123.2, 124.0, 124.8,
126.1, 127.4, 127.7, 127.7, 127.7, 128.1, 130.5, 134.1, 134.9, 138.7,
198.0.
HRMS (EI): m/z [M]+ calcd for C17H14OS: 266.0765; found: 266.0766.
Anal. Calcd for C17H14OS: C, 76.66; H, 5.30. Found: C, 76.60; H, 5.51.
(9-Methylsulfanyl)phenanthrene-3-carboxylic Acid (12)
A stirred suspension of 11 (400 mg, 1.50 mmol) in dioxane (50 mL)
was heated at 40 °C until complete dissolution of the solid. At the
same time, a solution of sodium hypobromite was prepared by the
dropwise addition of bromine (0.38 mL, 7.50 mmol) to an ice-cooled
solution of sodium hydroxide (1.05 g, 26.3 mmol) dissolved in H2O
(50 mL). The sodium hypobromite solution was then added dropwise
to the dioxane solution (complete addition took around 10 min) and
stirring was continued until TLC analysis indicated complete conver-
sion. The mixture was then cooled to r.t. and a saturated sodium sul-
fite solution (10 mL) was added to quench excess hypobromite. The
dioxane was removed in vacuo and the resultant suspension was
topped up with H2O and acidified to pH 1 by using concd HCl. Subse-
quent filtration gave a yellow solid, which was washed copiously with
water (100 mL) and then dried over P2O5. Recrystallisation from a
mixture of toluene and EtOH afforded 12.
Yield: 104 mg (26%); light-yellow solid; mp 242–246 °C.
1H NMR (400 MHz, DMSO-d6): δ = 2.72 (s, 3 H), 7.72–7.83 (m, 3 H),
8.02 (d, J = 8.0 Hz, 1 H), 8.12 (dd, J = 8.0, 1.2 Hz, 1 H), 8.19–8.25 (m,
1 H), 8.88 (d, J = 8.0 Hz, 1 H), 9.29 (s, 1 H), 13.09 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 14.1, 120.3, 123.4, 123.9, 124.4,
127.0, 127.0, 127.6, 127.6, 127.9, 129.4, 129.4, 134.1, 137.4, 167.4.
HRMS (ESI): m/z [M – H]– calcd for C16H12O2S: 267.0485; found:
267.0489.
Anal. Calcd for C16H12O2S·0.25 H2O: C, 70.44; H, 4.62. Found: C, 70.43;
H, 4.53.
Methyl 9-(3-Methoxy-3-oxoprop-1-en-1-yl)phenanthrene-3-car-
boxylate (14)
A flask was charged with 13 (30.1 g, 0.1 mol), palladium acetate (0.24
g, 0.1 mmol) and tri-o-tolylphosphine (1.28 g, 0.4 mmol). The flask
was then briefly evacuated and backfilled with argon three times. A
degassed solution of Et3N (40 mL, 0.26 mol) and methyl acrylate (12
mL, 0.13 mol) in DMF (300 mL) was then added to the flask by using a
cannula and the resultant mixture was heated at 100 °C for 18 h. After
cooling to r.t., any remaining volatile compounds were removed in
vacuo. Na2CO3 (10.6 g, 0.1 mol) was then added followed by methyl
iodide (12.5 mL, 0.2 mol), and the reaction mixture was stirred at r.t.
overnight. The mixture was then diluted with Et2O (500 mL) and the
organic layer was isolated, washed with H2O (2 × 200 mL) and dried
over MgSO4. Concentration in vacuo gave 14 as a 1:1 mixture of cis
and trans isomers.
Yield: 29.5 g (92%); pale-yellow solid; mp 186–188 °C.
1H NMR (300 MHz, CDCl3): δ = 3.85 (s, 3 H), 3.88 (s, 3 H), 3.94 (s, 3 H),
4.02 (s, 3 H), 4.17 (d, J = 6.0 Hz, 1 H), 5.45 (d, J = 6.0 Hz, 1 H), 6.59 (d,
J = 15.0 Hz, 1 H), 7.38–7.51 (m, 4 H), 7.65–7.75 (m, 2 H), 7.84–7.89 (m,
2 H), 7.99 (d, J = 7.8 Hz, 1 H), 8.06 (d, J = 7.8 Hz, 1 H), 8.14–8.17 (m,
2 H), 8.46 (d, J = 15.0 Hz, 1 H), 8.52 (d, J = 9.3 Hz, 1 H), 8.74–8.78 (m,
1 H), 9.12 (s, 1 H), 9.33 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 52.0, 52.3, 52.5, 52.6, 122.1, 123.3,
123.5, 124.0, 124.3, 124.6, 124.9, 125.1, 125.7, 126.6, 127.0, 127.6,
127.8, 128.4, 128.7, 129.0, 129.3, 130.2, 130.5, 130.7, 130.8, 133.4,
133.7, 133.9, 135.9, 142.2, 167.1, 167.2, 167.3, 172.7.
HRMS (CI): m/z [M + H]+ calcd for C20H16O4: 321.1127; found:
321.1125.
Methyl 9-Formylphenanthrene-3-carboxylate (15)
A solution of 14 (6.4 g, 20 mmol) in CH2Cl2 (30 mL) was diluted with
t-BuOH (150 mL) and H2O (50 mL) with vigorous stirring. TMAO (2.45
g, 22 mmol), OsO4 (0.5 g, 0.2 mmol) and tartaric acid (4.2 g, 20 mmol)
were added and the reaction was monitored by TLC analysis. When
all the starting material had been consumed, NaIO4 (21.3 g, 0.1 mol)
was added. The aldehyde precipitated out of solution almost immedi-
ately. After stirring for an additional 20 min, the solvent (mainly
t-BuOH) was removed in vacuo, and 15 was collected by filtration.
Yield: 5.17 g (98%); pale-yellow solid; mp 180–182 °C.
1H NMR (300 MHz, CDCl3): δ = 4.04 (s, 3 H), 7.71–7.80 (m, 2 H), 8.03
(d, J = 8.8 Hz, 1 H), 8.20–8.24 (m, 2 H), 8.74–8.77 (m, 1 H), 9.29–9.34
(m, 2 H), 10.38 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 52.7, 123.0, 125.2, 126.1, 127.2, 128.2,
128.4, 128.8, 130.5, 130.5, 132.2, 132.4, 132.8, 139.7, 166.9, 193.5.
MS (CI+): m/z (%) = 265 (100) [M + H]+.
Anal. Calcd for C17H12O3: C, 77.26; H, 4.58. Found: C, 77.22; H, 4.49.
Methyl 9-Bromophenanthrene-3-carboxylate (16)
A flask containing 137 (10.0 g, 33.2 mmol) was briefly evacuated and
backfilled with argon. Anhydrous MeOH (300 mL) was then added to
the flask by using a cannula followed by a catalytic amount of concen-
trated H2SO4 (3 mL). The resultant mixture was heated to reflux for
48 h, then cooled to r.t. before being concentrated in vacuo. The resul-
tant dark-orange solid was dissolved in CH2Cl2 (250 mL) and washed
with sat. aq NaHCO3 (3 × 50 mL), H2O (50 mL) and brine (50 mL). The
organic layer was dried over MgSO4 and concentrated in vacuo to af-
ford 16.
Yield: 9.06 g (87%); orange solid; mp 151–153 °C (Lit.4 155–155.5 °C).
1H NMR (400 MHz, CDCl3): δ = 4.03 (s, 3 H), 7.69–7.77 (m, 2 H), 7.78
(d, J = 8.4 Hz, 1 H), 8.07 (s, 1 H), 8.17 (dd, J = 8.4, 1.6 Hz, 1 H), 8.33–
8.37 (m, 1 H), 8.71–8.75 (m, 1 H), 9.32 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 52.4, 123.0, 124.6, 125.2, 127.1, 127.8,
128.0, 128.0, 128.2, 128.2, 129.1, 129.9, 130.5, 131.3, 134.7, 167.0.
General Procedure A; Wittig Reaction
To a stirred suspension of the appropriate triphenylphosphonium salt
(3.6 mmol) in THF (20 mL) was added dropwise potassium
bis(trimethylsilyl)amide (0.5 M in toluene, 7.2 mL, 3.6 mmol). The re-
sultant mixture was stirred for 30 min before being added dropwise
to a stirred solution of 15 (793 mg, 3 mmol) in THF (20 mL). After
complete addition, the mixture was stirred at r.t. for approximately
4 h, then the reaction was quenched with sat. aq NH4Cl (10 mL). The
mixture was diluted with Et2O (25 mL) and the organic layer was iso-
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lated and dried over MgSO4. Concentration in vacuo gave the crude
product, which was redissolved in Et2O (30 mL) and passed through a
short silica plug. Concentration in vacuo subsequently afforded the
alkene phenanthrenes 17a–c, which were utilised immediately in the
next step.
Methyl 9-Vinylphenanthrene-3-carboxylate (17a)
By following General Procedure A, methyltriphenylphosphonium io-
dide (1.46 g) afforded 17a as a light-yellow oil (677 mg, 86%).
Methyl 9-Prop-1-en-1-ylphenanthrene-3-carboxylate (17b)
By following General Procedure A, ethyltriphenylphosphonium bro-
mide (1.34 g) afforded 17b as a light-yellow oil (729 mg, 88%).
Methyl 9-But-1-en-1-ylphenanthrene-3-carboxylate (17c)
By following General Procedure A, propyltriphenylphosphonium bro-
mide (1.38 g) afforded 17c as a light-yellow oil (793 mg, 91%).
General Procedure B; Heck Reaction
A flask was charged with 16 (1.00 g, 3.17 mmol), palladium acetate
(7.2 mg, 1 mol%), tri-o-tolylphosphine (39 mg, 4 mol%), and (if a solid)
the appropriate alkene (3.96 mmol). The flask was then briefly evacu-
ated and backfilled with argon three times. Degassed anhydrous DMF
(25 mL) was then added followed by (if a liquid) the appropriate
alkene (3.96 mmol) and Et3N (1.11 mL, 7.93 mmol). The resultant
mixture was heated at 100 °C overnight. After cooling to r.t., the reac-
tion mixture was filtered through a Celite pad to remove any precipi-
tated Pd(0) and then poured into a stirred solution of EtOAc (100 mL),
H2O (100 mL) and aqueous 1 M HCl (10 mL). The organic layer was
subsequently isolated and the aqueous phase was further extracted
with EtOAc (2 × 30 mL). The organic extracts were pooled, washed
with H2O (5 × 100 mL) and brine (100 mL), and dried over MgSO4.
Concentration in vacuo afforded the crude alkene phenanthrenes
(17d–i), which were utilised immediately in the next step.
Methyl 9-Pent-1-en-1-ylphenanthrene-3-carboxylate (17d)
By following General Procedure B, 1-pentene (0.43 mL) afforded 17d
(850 mg, 88%) as a dark-orange oil.
Methyl 9-(4-Methylpent-1-en-1-yl)phenanthrene-3-carboxylate 
(17e)
By following General Procedure B, 4-methyl-1-pentene (0.50 mL) af-
forded 17e (924 mg, 91%) as a dark-orange oil.
Methyl 9-Hex-1-en-1-ylphenanthrene-3-carboxylate (17f)
By following General Procedure B, 1-hexene (0.49 mL) afforded 17f
(950 mg, 94%) as a dark-orange oil.
Methyl 9-Hept-1-en-1-ylphenanthrene-3-carboxylate (17g)
By following General Procedure B, 1-heptene (0.56 mL) afforded 17g
(760 mg, 72%) as a dark-orange oil.
Methyl 9-(2-Phenylethenyl)phenanthrene-3-carboxylate (17h)
By following General Procedure B, styrene (0.45 mL) afforded 17h
(911 mg, 85%) as a yellow/brown solid.
Methyl 9-[2-(4-Methoxycarbonyl)phenylethenyl]phenanthrene-3-
carboxylate (17i)
By following General Procedure B, methyl 4-vinylbenzoate (642 mg)
afforded 17i (1.02 g, 81%) as a yellow solid.
General Procedure C; Hydrogenation
The appropriate alkene phenanthrene was dissolved in EtOAc (100
mL) and the resultant solution was hydrogenated under 3 bar of hy-
drogen in the presence of 10 wt% palladium on activated carbon (50
mg) for 18 h. The reaction mixture was then filtered through a Celite
pad before being concentrated in vacuo. Purification of the resultant
residue by flash chromatography (EtOAc–hexane, 5 → 10%) afforded
the individual alkyl phenanthrenes.
Methyl 9-Ethylphenanthrene-3-carboxylate (18a)
By following General Procedure C, 17a (677 mg, 2.58 mmol) afforded
18a.
Yield: 613 mg (90%); white solid; mp 82–83 °C.
1H NMR (400 MHz, CDCl3): δ = 1.46 (t, J = 7.6 Hz, 3 H), 3.17 (q, J =
7.6 Hz, 2 H), 4.02 (s, 3 H), 7.61 (s, 1 H), 7.64–7.73 (m, 2 H), 7.85 (d, J =
8.4 Hz, 1 H), 8.11–8.15 (m, 1 H), 8.17 (dd, J = 8.4, 1.6 Hz, 1 H), 8.81–
8.85 (m, 1 H), 9.39 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 14.3, 26.3, 52.2, 123.4, 124.4, 124.4,
125.0, 126.5, 126.7, 127.0, 127.1, 128.1, 129.0, 130.8, 131.4, 134.9,
141.2, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C18H16O2: 265.1229; found:
265.1223.
Methyl 9-n-Propylphenanthrene-3-carboxylate (18b)
By following General Procedure C, 17b (729 mg, 2.62 mmol) afforded
18b.
Yield: 685 mg (94%); clear oil.
1H NMR (300 MHz, CDCl3): δ = 1.09 (t, J = 7.8 Hz, 3 H), 1.81 (m, J =
7.8 Hz, 2 H), 2.98 (t, J = 7.8 Hz, 2 H), 3.23 (s, 3 H), 7.43 (s, 1 H), 7.57–
7.66 (m, 2 H), 7.71 (d, J = 9.0 Hz, 1 H), 8.01–8.05 (m, 1 H), 8.14 (d, J =
9.0 Hz, 1 H), 8.72–8.75 (m, 1 H), 9.32 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 14.4, 22.9, 31.8, 52.2, 123.4, 124.5,
125.0, 125.4, 126.5, 126.7, 127.0, 127.1, 128.1, 129.0, 130.9, 131.5,
134.8, 139.6, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C19H18O2: 279.1380; found:
279.1373.
Methyl 9-n-Butylphenanthrene-3-carboxylate (18c)
By following General Procedure C, 17c (793 mg, 2.71 mmol) afforded
18c.
Yield: 729 mg (92%); clear oil.
1H NMR (400 MHz, CDCl3): δ = 1.04 (t, J = 7.8 Hz, 3 H), 1.50–1.59 (m,
2 H), 1.79–1.87 (m, 2 H), 3.12 (t, J = 7.8 Hz, 2 H), 4.05 (s, 3 H), 7.58–
7.59 (m, 1 H), 7.67–7.74 (m, 2 H), 7.82–7.86 (m, 1 H), 8.12–8.15 (m,
1 H), 8.20 (d, J = 8.0 Hz, 1 H), 8.82–8.85 (m, 1 H), 9.41 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 14.2, 23.1, 32.4, 33.4, 52.3, 123.5,
124.7, 125.1, 125.5, 126.6, 126.8, 127.1, 127.2, 128.2, 129.1, 131.0,
131.6, 135.0, 140.1, 167.6.
HRMS (CI): m/z [M + H]+ calcd for C20H20O2: 293.1542; found:
293.1553.
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Methyl 9-n-Pentylphenanthrene-3-carboxylate (18d)
By following General Procedure C, 17d (850 mg, 2.79 mmol) afforded
18d.
Yield: 815 mg (95%); viscous yellow oil.
1H NMR (400 MHz, CDCl3): δ = 0.94 (t, J = 6.8 Hz, 3 H), 1.36–1.53 (m,
4 H), 1.77–1.88 (m, 2 H), 3.13 (t, J = 8.0 Hz, 2 H), 4.02 (s, 3 H), 7.61 (s,
1 H), 7.64–7.75 (m, 2 H), 7.86 (d, J = 8.0 Hz, 1 H), 8.12–8.15 (m, 1 H),
8.18 (dd, J = 8.0, 1.6 Hz, 1 H), 8.82–8.86 (m, 1 H), 9.41 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 14.1, 22.6, 29.9, 32.1, 33.6, 52.2, 123.4,
124.6, 125.1, 125.4, 126.5, 126.7, 127.0, 127.0, 128.1, 129.0, 130.9,
131.4, 134.8, 140.0, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C21H22O2: 307.1698; found:
307.1696.
Methyl 9-(4-Methylpent-1-yl)phenanthrene-3-carboxylate (18e)
By following General Procedure C, 17e (924 mg, 2.90 mmol) afforded
18e.
Yield: 886 mg (95%); viscous yellow oil.
1H NMR (400 MHz, CDCl3): δ = 0.92 (d, J = 6.4 Hz, 6 H), 1.36–1.44 (m,
2 H), 1.58–1.70 (m, 1 H), 1.78–1.87 (m, 2 H), 3.11 (t, J = 7.6 Hz, 2 H),
4.02 (s, 3 H), 7.61 (s, 1 H), 7.65–7.74 (m, 2 H), 7.88–7.84 (d, J = 8.4 Hz,
1 H), 8.11–8.15 (m, 1 H), 8.18 (dd, J = 8.4, 1.6 Hz, 1 H), 8.82–8.86 (m,
1 H), 9.41 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 22.6, 28.0, 28.1, 33.9, 39.2, 52.5, 123.4,
124.6, 125.1, 125.4, 126.5, 126.7, 127.0, 127.1, 128.1, 129.0, 130.9,
131.4, 134.9, 140.1, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C22H24O2: 321.1855; found:
321.1855.
Methyl 9-n-Hexylphenanthrene-3-carboxylate (18f)
By following General Procedure C, 17f (950 mg, 2.98 mmol) afforded
18f.
Yield: 899 mg (94%); viscous yellow oil.
1H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.2 Hz, 3 H), 1.30–1.42 (m,
4 H), 1.43–1.55 (m, 2 H), 1.77–1.87 (m, 2 H), 3.12 (t, J = 7.6 Hz, 2 H),
4.02 (s, 3 H), 7.61 (s, 1 H), 7.65–7.74 (m, 2 H), 7.86 (d, J = 8.4 Hz, 1 H),
8.11–8.15 (m, 1 H), 8.18 (dd, J = 8.4, 1.6 Hz, 1 H), 8.82–8.86 (m, 1 H),
9.40 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 14.1, 22.7, 29.6, 30.2, 31.8, 33.6, 52.2,
123.4, 124.6, 125.1, 125.4, 126.5, 126.7, 127.0, 127.0, 128.1, 129.0,
130.9, 131.4, 134.9, 140.1, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C22H24O2: 321.1855; found:
321.1849.
Methyl 9-n-Heptylphenanthrene-3-carboxylate (18g)
By following General Procedure C, 17g (760 mg, 2.29 mmol) afforded
18g.
Yield: 500 mg (65%); viscous pale-yellow oil.
1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.2 Hz, 3 H), 1.24–1.54 (m,
8 H), 1.83 (quint, J = 7.6 Hz, 2 H), 3.13 (t, J = 7.6 Hz, 2 H), 4.02 (s, 3 H),
7.61 (s, 1 H), 7.65–7.74 (m, 2 H), 7.86 (d, J = 8.4 Hz, 1 H), 8.11–8.15 (m,
1 H), 8.18 (dd, J = 8.4, 1.6 Hz, 1 H), 8.82–8.86 (m, 1 H), 9.41 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 14.1, 22.7, 29.2, 29.8, 30.2, 31.9, 33.6,
52.2, 123.4, 124.6, 125.1, 125.4, 126.5, 126.7, 127.0, 127.1, 128.1,
129.0, 131.0, 131.4, 134.9, 140.1, 167.5.
HRMS (CI): m/z [M + Na]+ calcd for C23H26O2: 357.1831; found:
357.1822.
Methyl 9-Phenethylphenanthrene-3-carboxylate (18h)
By following General Procedure C, 17h (911 mg, 2.69 mmol) afforded
18h.
Yield: 599 mg (64%); viscous clear oil.
1H NMR (400 MHz, CDCl3): δ = 3.11–3.18 (m, 2 H), 3.42–3.48 (m, 2 H),
4.03 (s, 3 H), 7.21–7.26 (m, 1 H), 7.27–7.38 (m, 4 H), 7.60 (s, 1 H),
7.68–7.77 (m, 2 H), 7.84 (d, J = 8.8 Hz, 1 H), 8.18–8.22 (m, 1 H), 8.19
(dd, J = 8.8, 1.6 Hz, 1 H), 8.85–8.89 (m, 1 H), 9.42 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 35.5, 36.4, 52.3, 123.5, 124.4, 125.1,
125.7, 126.2, 126.6, 126.8, 127.2, 127.3, 128.2, 128.4, 128.5, 129.1,
130.9, 131.2, 134.7, 138.8, 141.7, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C24H20O2: 341.1542; found:
341.1543.
Methyl 9-[2-(4-Methoxycarbonylphenyl)ethyl]phenanthrene-3-
carboxylate (18i)
By following General Procedure C, 17i (1.02 g, 2.57 mmol) afforded
18i.
Yield: 625 mg (61%); viscous clear oil.
1H NMR (400 MHz, CDCl3): δ = 3.15–3.21 (m, 2 H), 3.40–3.47 (m, 2 H),
3.91 (s, 3 H), 4.02 (s, 3 H), 7.31 (d, J = 8.4 Hz, 2 H), 7.53 (s, 1 H), 7.67–
7.76 (m, 2 H), 7.80 (d, J = 8.0 Hz, 1 H), 7.98 (d, J = 8.4 Hz, 2 H), 8.13–
8.19 (m, 2 H), 8.83–8.88 (m, 1 H), 9.40 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 35.0, 36.4, 52.0, 52.3, 123.6, 124.2,
125.1, 125.8, 126.7, 126.9, 127.3, 127.4, 128.2, 128.5, 129.2, 129.9,
131.0, 131.1, 134.6, 138.2, 147.1, 167.1, 167.4.
HRMS (CI): m/z [M]+ calcd for C26H22O4: 398.1518; found: 398.1511.
General Procedure D; Ester Hydrolysis
The appropriate ester was dissolved in a mixture of either THF or di-
oxane (100 mL) and H2O (20 mL). A NaOH or KOH solution (3 equiv.)
dissolved in H2O (20 mL) was then added dropwise and the resulting
solution was heated either to reflux (THF) or to 75 °C (dioxane) until
TLC analysis indicated complete hydrolysis. The reaction mixture was
then cooled to r.t. and the organic solvent was removed in vacuo. The
resulting aqueous suspension was topped up with H2O, extracted
with Et2O (30 mL) and acidified to pH 1 by using aq 1 M HCl. The solid
that precipitated out of solution at this stage was filtered off, washed
copiously with H2O and then dried over P2O5 to afford the desired
acid. Several compounds required purification and were recrystal-
lised from an appropriate solvent.
9-Ethylphenanthrene-3-carboxylic Acid (19a)
By following General Procedure D, 18a (550 mg, 2.08 mmol), NaOH
(250 mg, 6.24 mmol) and dioxane afforded 19a.
Yield: 495 mg (95%); white solid; mp 245–249 °C (dec).
1H NMR (400 MHz, DMSO-d6): δ = 1.39 (t, J = 7.6 Hz, 3 H), 3.15 (q, J =
7.6 Hz, 2 H), 7.72–7.79 (m, 3 H), 8.02 (d, J = 8.4 Hz, 1 H), 8.12 (dd, J =
8.4, 1.6 Hz, 1 H), 8.17–8.22 (m, 1 H), 8.86–8.91 (m, 1 H), 9.33 (s, 1 H),
13.10 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 14.8, 26.0, 123.8, 124.7, 124.8,
124.9, 127.0, 127.6, 127.9, 128.6, 128.8, 130.5, 131.2, 134.7, 141.2,
168.0.
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HRMS (ESI): m/z [M – H]– calcd for C17H14O2: 249.0921; found:
249.0929.
Anal. Calcd for C17H14O2: C, 81.58; H, 5.64. Found: C, 81.75; H, 5.91.
9-n-Propylphenanthrene-3-carboxylic Acid (19b)
By following General Procedure D, 18b (525 mg, 1.89 mmol), NaOH
(227 mg, 5.67 mmol) and dioxane afforded 19b.
Yield: 465 mg (93%); white solid; mp 234–238 °C.
1H NMR (400 MHz, DMSO-d6): δ = 1.02 (t, J = 7.6 Hz, 3 H), 1.77 (m, J =
7.6 Hz, 2 H), 3.09 (t, J = 7.6 Hz, 2 H), 7.71–7.78 (m, 3 H), 8.00 (d, J =
8.4 Hz, 1 H), 8.11 (dd, J = 8.4, 1.6 Hz, 1 H), 8.16–8.21 (m, 1 H), 8.85–
8.90 (m, 1 H), 9.32 (s, 1 H), 13.12 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 14.0, 22.9, 34.6, 123.3, 124.3,
124.6, 125.3, 126.5, 127.1, 127.3, 128.1, 128.2, 128.3, 130.1, 130.8,
134.1, 139.2, 167.5.
HRMS (ESI): m/z [M – H]– calcd for C18H16O2: 263.1078; found
263.1085.
Anal. Calcd for C18H16O2: C, 81.79; H, 6.10. Found: C, 82.05; H, 6.39.
9-n-Butylphenanthrene-3-carboxylic acid (19c)
By following General Procedure D, 18c (650 mg, 2.22 mmol), NaOH
(266 mg, 6.66 mmol) and dioxane afforded 19c as a white solid which
was recrystallised from a mixture of toluene and EtOH.
Yield: 248 mg (40%); white solid; mp 208–211 °C;
1H NMR (400 MHz, DMSO-d6): δ = 0.95 (t, J = 7.6 Hz, 3 H), 1.45 (m, J =
7.6 Hz, 2 H), 1.73 (quint, J = 7.6 Hz, 2 H), 3.12 (t, J = 7.2 Hz, 2 H), 7.71–
7.79 (m, 3 H), 8.01 (d, J = 8.0 Hz, 1 H), 8.11 (dd, J = 8.0, 1.2 Hz, 1 H),
8.16–8.21 (m, 1 H), 8.85–8.90 (m, 1 H), 9.32 (s, 1 H), 13.08 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 13.8, 22.2, 31.9, 32.3, 123.3, 124.3,
124.6, 125.2, 126.5, 127.1, 127.3, 128.0, 128.2, 128.3, 130.1, 130.8,
134.1, 139.4, 167.5.
HRMS (ESI): m/z [M – H]– calcd for C19H18O2: 277.1234; found
277.1232.
Anal. Calcd for C19H18O2: C, 81.99; H, 6.52. Found: C, 81.85; H, 6.41.
9-n-Pentylphenanthrene-3-carboxylic Acid (19d)
By following General Procedure D, 18d (573 mg, 1.88 mmol), NaOH
(226 mg, 5.64 mmol) and dioxane afforded 19d as a white solid,
which was recrystallised from toluene.
Yield: 141 mg (26%); white solid; mp 194–197 °C.
1H NMR (400 MHz, DMSO-d6): δ = 0.87 (t, J = 7.2 Hz, 3 H), 1.29–1.47
(m, 4 H), 1.74 (quint, J = 7.2 Hz, 2 H), 3.10 (t, J = 7.2 Hz, 2 H), 7.70–7.79
(m, 3 H), 8.00 (d, J = 8.4 Hz, 1 H), 8.11 (dd, J = 8.4, 1.6 Hz, 1 H), 8.15–
8.20 (m, 1 H), 8.84–8.92 (m, 1 H), 9.33 (s, 1 H), 13.13 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 14.5, 22.6, 30.0, 31.9, 33.2, 123.9,
124.9, 125.1, 125.8, 127.2, 127.6, 127.9, 128.6, 128.8, 128.9, 130.7,
131.4, 134.7, 140.0, 168.2.
MS (ESI–): m/z (%) = 291 (100) [M – H]–, 247 (46).
Anal. Calcd for C20H20O2: C, 82.16; H, 6.89. Found: C, 82.00; H, 6.82.
9-(4-Methylpent-1-yl)phenanthrene-3-carboxylic Acid (3)
By following General Procedure D, 18e (675 mg, 2.11 mmol), NaOH
(253 mg, 6.33 mmol) and dioxane afforded 3 as a white solid, which
was recrystallised from toluene.
Yield: 264 mg (41%); white solid; mp 193–196 °C.
1H NMR (400 MHz, DMSO-d6): δ = 0.82 (d, J = 6.4 Hz, 6 H), 1.24–1.33
(m, 2 H), 1.48–1.60 (m, 1 H), 1.64–1.74 (m, 2 H), 3.03 (t, J = 8.0 Hz,
2 H), 7.66–7.77 (m, 3 H), 7.97 (d, J = 8.4 Hz, 1 H), 8.09–8.16 (m, 2 H),
8.82–8.89 (m, 1 H), 9.32 (s, 1 H), 13.13 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 22.4, 27.3, 27.6, 32.8, 38.4, 123.2,
124.3, 124.5, 125.1, 126.5, 127.0, 127.3, 128.0, 128.2, 128.3, 130.1,
130.7, 134.1, 139.4, 167.5.
MS (ESI–): m/z (%) = 305 (100) [M – H]–, 261 (25).
Anal. Calcd for C21H22O2: C, 82.32; H, 7.24. Found: C, 82.30; H, 7.17.
9-n-Hexylphenanthrene-3-carboxylic Acid (19f)
By following General Procedure D, 18f (679 mg, 2.12 mmol), NaOH
(254 mg, 6.36 mmol) and dioxane afforded 19f as a white solid, which
was recrystallised from toluene.
Yield: 221 mg (34%); white solid; mp 196–199 °C.
1H NMR (400 MHz, DMSO-d6): δ = 0.85 (t, J = 7.2 Hz, 3 H), 1.22–1.37
(m, 4 H), 1.43 (quint, J = 7.2 Hz, 2 H), 1.73 (quint, J = 7.2 Hz, 2 H), 3.10
(t, J = 7.2 Hz, 2 H), 7.71–7.79 (m, 3 H), 8.00 (d, J = 8.4 Hz, 1 H), 8.11
(dd, J = 8.4, 1.6 Hz, 1 H), 8.14–8.20 (m, 1 H), 8.84–8.91 (m, 1 H), 9.32
(s, 1 H), 13.12 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 13.9, 22.1, 28.8, 29.7, 31.1, 32.7,
123.3, 124.3, 124.6, 125.2, 126.6, 127.1, 127.3, 128.1, 128.2, 128.3,
130.1, 130.8, 134.1, 139.4, 167.6.
MS (ESI–): m/z (%) = 305 (100) [M – H]–, 261 (20).
Anal. Calcd for C21H22O2: C, 82.32; H, 7.24. Found: C, 82.01; H, 7.08.
9-n-Heptylphenanthrene-3-carboxylic Acid (19g)
By following General Procedure D, 18g (450 mg, 1.35 mmol), NaOH
(162 mg, 4.05 mmol) and dioxane afforded 19g as a white solid,
which was recrystallised from toluene.
Yield: 317 mg (73%); white solid; mp 185–188 °C.
1H NMR (400 MHz, DMSO-d6): δ = 0.83 (t, J = 7.2 Hz, 3 H), 1.18–1.45
(m, 8 H), 1.72 (quint, J = 7.6 Hz, 2 H), 3.08 (t, J = 7.6 Hz, 2 H), 7.70–7.78
(m, 3 H), 7.99 (d, J = 8.0 Hz, 1 H), 8.11 (dd, J = 8.0, 1.2 Hz, 1 H), 8.14–
8.19 (m, 1 H), 8.85–8.90 (m, 1 H), 9.32 (s, 1 H), 13.09 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 13.9, 22.0, 28.5, 29.1, 29.8, 31.2,
32.6, 123.3, 124.2, 124.6, 125.2, 126.6, 127.0, 127.3, 128.2, 128.3,
130.1, 130.8, 134.1, 139.4, 167.6.
HRMS (ESI): m/z [M – H]– calcd for C22H24O2: 319.1704; found:
319.1707.
Anal. Calcd for C22H24O2: C, 82.46; H, 7.55. Found: C, 82.12; H, 7.50.
9-Phenethylphenanthrene-3-carboxylic Acid (19h)
By following General Procedure D, 18h (512 mg, 1.50 mmol), NaOH
(180 mg, 4.50 mmol) and dioxane afforded 19h as a white solid,
which was recrystallised from a mixture of toluene and EtOH.
Yield: 105 mg (22%); white solid; mp 236–237 °C.
1H NMR (400 MHz, DMSO-d6): δ = 3.07 (t, J = 8.0 Hz, 2 H), 3.41 (t, J =
8.0 Hz, 2 H), 7.18–7.24 (m, 1 H), 7.27–7.37 (m, 4 H), 7.73–7.81 (m,
3 H), 7.98 (d, J = 8.4 Hz, 1 H), 8.11 (dd, J = 8.4, 1.6 Hz, 1 H), 8.26–8.32
(m, 1 H), 8.86–8.93 (m, 1 H), 9.34 (s, 1 H), 13.10 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 34.6, 35.7, 123.3, 124.3, 124.5,
125.4, 125.9, 126.6, 127.1, 127.5, 128.0, 128.1, 128.2, 128.3, 128.3,
130.1, 130.7, 134.0, 138.5, 141.4, 167.5.
MS (ESI–): m/z (%) = 325 (100) [M – H]–.
Anal. Calcd for C23H18O2: C, 84.64; H, 5.56. Found: C, 84.53; H, 5.58.
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9-[2-(4-Carboxyphenyl)ethyl]phenanthrene-3-carboxylic Acid 
(19j)
By following General Procedure D, 18i (400 mg, 1.00 mmol), KOH
(337 mg, 6.00 mmol) and THF afforded 19j.
Yield: 216 mg (58%); off-white solid; mp >250 °C.
1H NMR (400 MHz, DMSO-d6): δ = 3.15 (t, J = 8.0 Hz, 2 H), 3.45 (t, J =
8.0 Hz, 2 H), 7.47 (d, J = 8.4 Hz, 2 H), 7.75–7.81 (m, 3 H), 7.88 (d, J =
8.4 Hz, 2 H), 7.98 (d, J = 8.0 Hz, 1 H), 8.11 (dd, J = 8.0, 1.6 Hz, 1 H),
8.27–8.32 (m, 1 H), 8.87–8.93 (m, 1 H), 9.34 (s, 1 H), 12.97 (br s, 1 H),
13.15 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 34.1, 35.6, 123.3, 124.3, 124.6,
125.5, 126.6, 127.2, 127.5, 128.2, 128.3, 128.4, 128.5, 128.6, 129.4,
130.1, 130.6, 134.0, 138.2, 146.7, 167.2, 167.5.
HRMS (ESI): m/z [M – H]– calcd for C24H18O4: 369.1132; found:
369.1142.
Anal. Calcd for C24H18O4·0.63 H2O: C, 75.51; H, 5.09. Found: C, 75.82;
H, 5.48.
Methyl 9-Vinylphenanthrene-3-carboxylate (17a)
A flask containing 16 (1.00 g, 3.17 mmol) was evacuated and back-
filled with argon three times. Anhydrous toluene (50 mL) was added
to the flask by using a cannula and the resultant solution was de-
gassed with argon for approximately 30 min. Pd(PPh3)4 (109.9 mg, 3
mol%) was then added and the mixture was degassed for a further
10 min before vinyl(tri-n-butyl)tin (1.12 mL, 3.80 mmol) was added.
The resultant mixture was heated at reflux for 4 h before cooling to
r.t. and filtered through Celite to remove any precipitated Pd(0). The
filtrate was then poured into a stirring mixture of EtOAc (50 mL) and
sat. aq NH4Cl (50 mL). The organic layer was isolated and washed with
aq 1 M KF (2 × 50 mL) to remove any tin by-products. The white solid
(Bu3SnF), which precipitated from solution after the first wash, was
removed by filtration through Celite. The organic layer was then iso-
lated, washed with H2O (50 mL), brine (50 mL), dried over MgSO4 and
concentrated in vacuo to afford a dark-orange oil. Purification by
flash chromatography (EtOAc–hexane, 5%) afforded 17a.
Yield: 550 mg (66%); pale-yellow oil that partially solidified on stand-
ing.
1H NMR (400 MHz, CDCl3): δ = 4.03 (s, 3 H), 5.59 (dd, J = 10.8, 1.6 Hz,
1 H), 5.91 (dd, J = 17.2, 1.6 Hz, 1 H), 7.48 (ddd, J = 17.2, 10.8, 0.8 Hz,
1 H), 7.65–7.77 (m, 2 H), 7.86 (s, 1 H), 7.93 (d, J = 8.4 Hz, 1 H), 8.16–
8.22 (m, 2 H), 8.81–8.86 (m, 1 H), 9.41 (d, J = 0.8 Hz, 1 H).
13C NMR (100 MHz, CDCl3): δ = 52.3, 118.7, 123.4, 124.1, 124.9, 125.2,
126.8, 127.3, 127.3, 127.8, 128.9, 129.8, 130.7, 130.8, 134.8, 134.9,
137.4, 167.5.
HRMS (ES): m/z [M]+ calcd for C18H14O2: 262.0994; found: 262.0999.
Methyl 9-Cyclopropylphenanthrene-3-carboxylate (20)
Diiodomethane (1.82 g, 6.8 mmol) was dissolved in anhydrous CH2Cl2
(10 mL) and ZnEt2 (1.0 M in hexane, 3.4 mL, 3.4 mmol) was added to
this solution at 0 °C, followed by a solution of 17a (450 mg, 1.7 mmol)
in CH2Cl2 (10 mL). The mixture was stirred vigorously overnight then
the reaction was quenched with aq 1 M HCl. The mixture was extract-
ed with Et2O (50 mL) and the organic layer was isolated, dried over
MgSO4 and concentrated in vacuo. The resultant residue was purified
by flash chromatography (EtOAc–hexane, 5%) to afford 20.
Yield: 400 mg (85%); viscous clear oil.
1H NMR (300 MHz, CDCl3): δ = 0.83–0.89 (m, 2 H), 1.10–1.16 (m, 2 H),
2.31–2.40 (m, 1 H), 4.02 (s, 3 H), 7.53 (s, 1 H), 7.67–7.76 (m, 2 H), 7.82
(d, J = 9.0 Hz, 1 H), 8.16 (d, J = 9.0 Hz, 1 H), 8.49–8.53 (m, 1 H), 8.79–
8.82 (m, 1 H), 9.38 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 6.5, 6.5, 14.1, 52.3, 123.2, 123.9, 125.1,
125.3, 126.6, 127.0, 127.1, 127.3, 128.3, 129.1, 130.7, 132.9, 135.0,
140.4, 167.6.
HRMS (CI): m/z [M + H]+ calcd for C19H16O2: 277.1229; found:
277.1231.
9-Cyclopropylphenanthrene-3-carboxylic Acid (2)
Compound 20 (350 mg, 1.27 mmol) was dissolved in dioxane (10 mL)
and sat. aq LiOH was added dropwise until the reaction mixture be-
came a slurry (ca. 1 mL). The mixture was stirred at r.t. overnight,
then extracted with Et2O (20 mL) before being acidified to pH 1 with
aq 1 M HCl. The acid precipitated out of solution and was subsequent-
ly collected by filtration, washed with H2O and dried over P2O5 to af-
ford 2.
Yield: 310 mg (93%); white solid; mp >250 °C.
1H NMR (300 MHz, DMSO-d6): δ = 0.81–0.85 (m, 2 H), 1.10–1.15 (m,
2 H), 2.41–2.49 (m, 1 H), 7.69 (s, 1 H), 7.77–7.80 (m, 2 H), 8.02 (d, J =
8.8 Hz, 1 H), 8.10 (d, J = 8.8 Hz, 1 H), 8.52–8.54 (m, 1 H), 8.85–8.88 (m,
1 H), 9.31 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 7.0, 7.0, 13.9, 123.4, 123.5, 124.7,
125.5, 127.0, 127.8, 127.9, 128.6, 128.7, 129.0, 130.3, 132.6, 134.7,
140.4, 168.0.
MS (ESI–): m/z (%) = 261 (100) [M – H]–.
Anal. Calcd for C18H14O2: C, 82.42; H, 5.38. Found: C, 82.84; H, 5.47.
Methyl 9-(Thiophen-3-yl)phenanthrene-3-carboxylate (21)
A flame-dried flask was successively charged with 16 (1.00 g, 3.17
mmol), 3-thienylboronic acid (573 mg, 4.48 mmol), K2CO3 (1.31 g,
9.51 mmol) and Pd(dppf)Cl2·CH2Cl2 (261 mg, 0.32 mmol). After each
addition, the flask was briefly evacuated and backfilled with argon.
Degassed anhydrous DME (75 mL) was then added into the flask by
using a cannula and the resultant mixture was stirred at 80 °C for
24 h. After cooling to r.t., the reaction mixture was diluted with EtOAc
(100 mL) and H2O (20 mL). The organic layer was isolated and washed
with H2O (2 × 25 mL) and then brine (2 × 25 mL). After drying over
MgSO4, concentration in vacuo afforded a dark-brown/black residue,
which was partially purified by flash chromatography (EtOAc–hex-
ane, 10%) to give a pale-yellow solid (618 mg, 61%), which 1H NMR
analysis showed was a mixture of 21 and 16 (ca. 75:25). The mixture
was taken forward to the next step without further purification.
Compound 21: 1H NMR (400 MHz, CDCl3): δ = 4.04 (s, 3 H), 7.35 (dd,
J = 4.8, 1.6 Hz, 1 H), 7.49 (dd, J = 2.8, 1.6 Hz, 1 H), 7.51 (dd, J = 4.8,
2.8 Hz, 1 H), 7.59–7.64 (m, 1 H), 7.71–7.76 (m, 1 H), 7.77 (s, 1 H), 7.91
(d, J = 8.4 Hz, 1 H), 8.08 (dd, J = 8.4, 1.2, 1 H), 8.21 (dd, J = 8.4, 1.6 Hz,
1 H), 8.87 (d, J = 8.4 Hz, 1 H), 9.45 (s, 1 H).
9-(Thiophen-3-yl)phenanthrene-3-carboxylic Acid (22)
By following General Procedure D, 21 (541 mg, 1.70 mmol), NaOH
(204 mg, 5.10 mmol) and dioxane afforded a pale-yellow solid, which
was recrystallised four times from glacial acetic acid to give 22.
Yield: 117 mg (23%); mp >250 °C.
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1H NMR (400 MHz, DMSO-d6): δ = 7.42 (dd, J = 4.8, 1.6 Hz, 1 H), 7.68–
7.73 (m, 1 H), 7.77–7.83 (m, 3 H), 7.94 (s, 1 H), 8.04 (dd, J = 8.4, 1.2 Hz,
1 H), 8.11 (d, J = 8.4 Hz, 1 H), 8.16 (dd, J = 8.4, 1.6 Hz, 1 H), 8.95 (d, J =
8.4 Hz, 1 H), 9.39 (s, 1 H), 13.15 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 123.7, 124.8, 125.3, 126.8, 127.0,
127.3, 128.0, 128.0, 129.1, 129.3, 129.4, 129.8, 130.7, 131.0, 134.2,
135.8, 140.3, 168.0.
HRMS (ESI): m/z [M – H]– calcd for C19H12O2S: 303.0485; found:
303.0495.
Anal. Calcd for C19H12O2S·0.55 H2O: C, 72.61; H, 4.20. Found: C, 72.61;
H, 4.02.
Methyl 9-(4-Methoxy-4-oxobutan-2-yl)phenanthrene-3-carboxyl-
ate (23)
To a cold (–78 °C) stirring mixture of CuI (25.2 g, 0.13 mol) and NaI
(36 g, 0.24 mol) in Me2S (79 mL) and CH2Cl2 (72 mL), was added meth-
ylmagnesium chloride (3.0 M in THF, 41 mL, 0.12 mol) and TMSCl (31
mL, 0.24 mol). The mixture was then stirred for 30 min at –78 °C and
a solution of 14 (7.7 g, 24 mmol) in CH2Cl2 (72 mL) was added. The
resultant mixture was stirred at –78 °C for 10 min and then slowly
warmed to r.t. After stirring for 3 h, the reaction was quenched with
sat. aq NH4Cl. The organic layer was isolated and the aqueous phase
was extracted with Et2O (100 mL). The organic layers were pooled,
dried over MgSO4, and concentrated in vacuo. Purification of the re-
sultant residue by flash column chromatography (EtOAc–hexane, 5%)
afforded 23.
Yield: 4.83 g (60%); light coloured oil.
1H NMR (300 MHz, CDCl3): δ = 1.42 (d, J = 7.8 Hz, 3 H), 2.69 (dd, J = 7.8,
12.0 Hz, 1 H), 2.89 (dd, J = 7.8, 12.0 Hz, 1 H), 3.87 (s, 3 H), 3.93 (s, 3 H),
4.06 (m, J = 7.8 Hz, 1 H), 7.75–7.78 (m, 2 H), 7.84 (s, 1 H), 7.92 (d, J =
8.7 Hz, 1 H), 7.94 (d, J = 8.7 Hz, 1 H), 8.00–8.10 (m, 1 H), 8.92–8.95 (m,
1 H), 9.33 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 21.7, 31.0, 41.6, 54.3, 56.7, 122.8, 124.0,
124.3, 124.7, 127.0, 127.6, 128.0, 128.7, 128.8, 129.1, 130.6, 130.7,
134.1, 143.4, 168.0, 173.8.
HRMS (CI): m/z [M + H]+ calcd for C21H20O4: 337.1440; found:
337.1442.
9-(4-Methoxy-4-oxobutan-2-yl)phenanthrene-3-carboxylic Acid 
(24)
By following General Procedure D, 23 (508 mg, 1.51 mmol), NaOH
(362.4 mg, 9.06 mmol) and dioxane afforded 24.
Yield: 377 mg (81%); white solid; mp >250 °C.
1H NMR (300 MHz, DMSO-d6): δ = 1.42 (d, J = 7.8 Hz, 3 H), 2.68 (dd, J =
7.8, 12.0 Hz, 1 H), 2.87 (dd, J = 7.8, 12.0 Hz, 1 H), 4.07 (m, J = 7.8 Hz,
1 H), 7.77–7.80 (m, 2 H), 7.86 (s, 1 H), 8.06 (d, J = 8.7 Hz, 1 H), 8.13 (d,
J = 8.7 Hz, 1 H), 8.27–8.30 (m, 1 H), 8.90–8.93 (m, 1 H), 9.33 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 21.7, 31.0, 41.6, 122.8, 124.0, 124.3,
124.7, 127.0, 127.6, 128.0, 128.7, 128.8, 129.1, 130.6, 130.7, 134.5,
143.4, 168.0, 173.8.
HRMS (ESI): m/z [M – H]– calcd for C19H16O4: 307.0976; found:
307.0969.
Anal. Calcd for C19H16O4: C, 74.01; H, 5.23. Found: C, 74.07; H, 5.18.
Methyl 9-(3-Hydroxy-2-methoxy-4-oxobutan-2-yl)phenanthrene-
3-carboxylate (25)
To a stirring solution of 23 (2.74 g, 8.15 mmol) in anhydrous THF (40
mL) at –78 °C, was added dropwise KHMDS (0.5 M in toluene, 17.3
mL, 8.65 mmol) followed by a solution of 2-tosyl-3-phenyloxaziri-
dine8 (3.2 g, 12.25 mmol) in THF (20 mL). After complete addition, the
mixture was warmed to r.t. and stirred for approximately 2 h. H2O (30
mL) and Et2O (60 mL) were then added and the organic layer was iso-
lated and washed with sat. sodium sulfite solution (20 mL), aq 1 M
HCl (20 mL), and brine (20 mL). Concentration in vacuo afforded 25 as
an oil, which was utilised in the next step without further purifica-
tion or analysis.
Methyl 9-(1-Oxopropan-2-yl)phenanthrene-3-carboxylate (26)
A stirred solution of 25 in anhydrous THF (20 mL) was cooled to 0 °C
and LiBH4 (227 mg, 12.3 mmol) was added portionwise over a period
of 10 min. After complete addition, the mixture was stirred for
30 min at 0 °C and then at r.t. until TLC analysis indicated complete
conversion. The reaction was then quenched by the addition of aq 1
M HCl (5 mL) and extracted with Et2O (2 × 30 mL). The organic layers
were pooled, dried over MgSO4 and concentrated in vacuo to obtain
the crude 1,2-diol as an orange oil. This intermediate was dissolved in
a mixture of t-BuOH and H2O (30 mL, 4:1), and NaIO4 (5.13 g, 24
mmol) was added to the solution. The resultant mixture was stirred
at r.t. for 30 min before the reaction was quenched by the addition of
H2O (20 mL). The aqueous mixture was then extracted with Et2O
(2 × 30 mL) and the organic layers were pooled, dried over MgSO4,
and concentrated in vacuo. Purification of the resultant residue by
flash chromatography (EtOAc–hexane, 5%) afforded 26.
Yield: 1.55 g (65%); viscous light-orange oil.
1H NMR (400 MHz, CDCl3): δ = 1.67 (d, J = 7.2 Hz, 3 H), 4.03 (s, 3 H),
4.42 (q, J = 7.2 Hz, 1 H), 7.57 (s, 1 H), 7.68–7.79 (m, 2 H), 7.89 (d, J =
8.4 Hz, 1 H), 8.06–8.10 (m, 1 H), 8.21 (dd, J = 8.4, 1.6 Hz, 1 H), 8.85–
8.89 (m, 1 H), 9.41 (s, 1 H), 9.82 (d, J = 1.6 Hz, 1 H).
13C NMR (100 MHz, CDCl3): δ = 14.4, 49.0, 52.3, 123.8, 123.9, 125.0,
126.0, 126.9, 127.3, 127.6, 128.1, 128.6, 129.5, 130.7, 131.2, 134.2,
135.3, 167.2, 200.9.
HRMS (ESI): m/z [M + Na]+ calcd for C19H16O3: 315.0997; found:
315.0992.
Methyl 9-(1-Hydroxypropan-2-yl)phenanthrene-3-carboxylate 
(27)
To a stirred solution of 26 (1.0 g, 3.42 mmol) in anhydrous THF (100
mL) was added portionwise NaBH4 (388 mg, 10.26 mmol). i-PrOH (2
mL) was then added and the resultant suspension was stirred at r.t.
until TLC analysis indicated complete reduction. Excess NaBH4 was
then destroyed by the dropwise addition of H2O. The solvent was then
removed in vacuo and the resultant residue was dissolved in a mix-
ture of EtOAc (50 mL) and H2O (50 mL). The organic layer was isolated
and the aqueous layer was further extracted with EtOAc (2 × 25 mL).
The organic layers were pooled, washed with H2O (25 mL), brine (25
mL), dried over MgSO4 and concentrated in vacuo. Purification of the
resultant residue by flash column chromatography (EtOAc–hexane,
10%) afforded 27.
Yield: 985 mg (98%); viscous pale-yellow oil.
1H NMR (300 MHz, CDCl3): δ = 1.51 (d, J = 6.7 Hz, 3 H), 3.85–3.91 (m,
2 H), 4.00 (s, 3 H), 4.05 (m, 1 H), 7.64–7.73 (m, 3 H), 7.87 (d, J = 8.8 Hz,
1 H), 8.15–8.22 (m, 2 H), 8.83 (d, J = 8.8 Hz, 1 H), 9.37 (s, 1 H).
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13C NMR (75 MHz, CDCl3): δ = 17.8, 21.1, 52.4, 67.7, 123.4, 123.7,
125.1, 126.7, 127.0, 127.3, 127.6, 128.6, 129.1, 131.1, 131.3, 134.5,
140.8, 167.5.
HRMS (CI): m/z [M + H]+ calcd for C19H18O3: 295.1329; found:
295.1320.
9-(1-Hydroxypropan-2-yl)phenanthrene-3-carboxylic Acid (28)
By following General Procedure D, 27 (301 mg, 1.02 mmol), NaOH
(122 mg, 3.06 mmol), and dioxane afforded 28.
Yield: 213 mg (75%); white solid; mp >250 °C.
1H NMR (400 MHz, DMSO-d6): δ = 1.44 (d, J = 8.0 Hz, 3 H), 3.54–3.64
(m, 1 H), 3.69–3.78 (m, 1 H), 3.79–3.87 (m, 1 H), 4.82 (s, 1 H), 8.05 (d,
J = 8.0 Hz, 1 H), 8.12 (d, J = 8.0 Hz, 1 H), 8.27–8.34 (m, 1 H), 8.86–8.93
(m, 1 H), 9.33 (s, 1 H), 13.14 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 17.8, 36.5, 66.3, 123.2, 123.4,
124.1, 124.3, 126.5, 127.0, 127.4, 128.1, 128.6, 130.1, 130.9, 134.1,
141.6, 167.6.
HRMS-ESI: m/z [M – H]– calcd for C18H16O3: 279.1027; found
279.1019.
Anal. Calcd for C18H16O3: C, 77.12; H, 5.75. Found: C, 77.37; H, 5.89.
Methyl 9-(Propan-2-yl)phenanthrene-3-carboxylate (29)
To a stirred solution of 27 (505 mg, 1.72 mmol) in CH2Cl2 (20 mL) at
0 °C was added Et3N (0.25 mL, 1.80 mmol) followed by methanesulfo-
nyl chloride (0.14 mL, 1.80 mmol). The resultant mixture was stirred
at 0 °C for 1 h and then at r.t. for 3 h. After this time, the reaction was
diluted with CH2Cl2 (20 mL) and H2O (20 mL) and the organic layer
was isolated, washed with aq 1 M HCl (10 mL), brine (10 mL), dried
over MgSO4 and concentrated in vacuo. The crude mesylate thus ob-
tained was dissolved in acetone (75 mL) and sodium iodide (645 mg,
4.3 mmol) was added to the solution. The resultant mixture was heat-
ed at reflux for 24 h before cooling to r.t. Filtration then removed any
solids, with the filter cake being rinsed with acetone. The filtrate and
washes were combined and concentrated in vacuo. The resultant resi-
due was dissolved in Et2O (40 mL) and washed with H2O (20 mL), sat.
sodium sulfite solution (15 mL), H2O (20 mL), and dried over MgSO4.
Concentration in vacuo afforded the crude iodo compound, which
was then dissolved in dioxane (100 mL). Et3N (0.25 mL, 1.80 mmol)
was added and the resultant solution was hydrogenated under 3 bar
of hydrogen in the presence of 10 wt% palladium on activated carbon
(50 mg) for 18 h. The reaction mixture was then filtered through a
Celite pad before being concentrated in vacuo. The resultant residue
was taken up in CH2Cl2 (50 mL) and washed successively with aq 1 M
HCl, H2O, and brine (25 mL each). Drying over MgSO4 followed by
concentration in vacuo gave a residue, which was purified by flash
column chromatography (EtOAc–hexane, 10%) to afford 29.
Yield: 349 mg (73%); pale-yellow oil.
1H NMR (300 MHz, CDCl3): δ = 1.49 (d, J = 7.2 Hz, 6 H), 3.74 (sept, J =
7.2 Hz, 1 H), 3.85 (s, 3 H), 7.66–7.72 (m, 3 H), 7.86 (d, J = 8.7 Hz, 1 H),
8.18–8.20 (m, 2 H), 8.82–8.86 (m, 1 H), 9.40 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 23.2, 28.8, 52.2, 121.7, 123.5, 124.1,
124.9, 126.5, 126.6, 127.0, 127.1, 128.3, 128.8, 131.0, 134.9, 145.5,
167.5.
HRMS (CI): m/z [M + H]+ calcd for C19H18O2: 279.1380; found:
279.1371.
9-(Propan-2-yl)phenanthrene-3-carboxylic Acid (30)
By following General Procedure D, 29 (205 mg, 0.74 mmol), NaOH (89
mg, 2.22 mmol) and dioxane afforded 30.
Yield: 166 mg (85%); white solid; mp 226–230 °C.
1H NMR (400 MHz, DMSO-d6): δ = 1.42 (d, J = 6.8 Hz, 6 H), 3.78 (sept,
J = 6.8 Hz, 1 H), 7.72–7.79 (m, 2 H), 7.83 (s, 1 H), 8.06 (d, J = 8.4 Hz,
1 H), 8.12 (dd, J = 8.4, 1.6 Hz, 1 H), 8.24–8.31 (m, 1 H), 8.86–8.92 (m,
1 H), 9.33 (s, 1 H), 13.06 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 23.0, 28.1, 121.6, 123.4, 124.1,
124.2, 126.5, 127.0, 127.3, 128.1, 128.1, 128.5, 130.1, 130.3, 134.1,
145.0, 167.5.
HRMS (ESI): m/z [M – H]– calcd for C18H16O2: 263.1078; found:
263.1070.
Anal. Calcd for C18H16O2: C, 81.79; H, 6.10. Found: C, 81.65; H, 6.01.
Methyl 9-(Hydroxymethyl)phenanthrene-3-carboxylate (31)
To a stirred solution of 15 (1.10 g, 4.16 mmol) in anhydrous THF (150
mL) was added slowly and portionwise NaBH4 (472 mg, 12.48 mmol).
i-PrOH (2 mL) was then added and the resultant suspension was
stirred at r.t. until TLC analysis indicated complete reduction. Excess
NaBH4 was destroyed by the dropwise addition of H2O. Concentration
in vacuo afforded a solid, which was dissolved in a mixture of EtOAc
(50 mL) and H2O (50 mL). The organic layer was isolated and the
aqueous layer was further extracted with EtOAc (2 × 25 mL). The or-
ganic layers were pooled, washed with H2O (25 mL) and brine (25
mL), dried over MgSO4 and concentrated in vacuo to afford 31.
Yield: 1.05 g (95%); pale-yellow solid; mp 179–182 °C.
1H NMR (400 MHz, DMSO-d6): δ = 3.96 (s, 3 H), 5.05 (d, J = 5.6 Hz,
2 H), 5.52 (t, J = 5.6 Hz, 1 H), 7.69–7.81 (m, 2 H), 7.96 (s, 1 H), 8.07–
8.18 (m, 3 H), 8.85–8.91 (m, 1 H), 9.34 (s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 52.2, 61.2, 123.2, 123.3, 124.3,
124.3, 126.3, 127.2, 127.2, 127.4, 128.7, 128.9, 129.7, 129.8, 134.2,
139.1, 166.4.
HRMS (ESI): m/z [M + Na]+ calcd for C17H14O3: 289.0835; found:
289.0832.
Anal. Calcd for C17H14O3: C, 76.68; H, 5.30. Found: C, 76.35; H, 5.31.
9-(Hydroxymethyl)phenanthrene-3-carboxylic Acid (32)
By following General Procedure D, 31 (500 mg, 1.88 mmol), NaOH
(226 mg, 5.64 mmol) and dioxane afforded 32 as a light-yellow solid
which was recrystallised from a mixture of toluene and EtOH.
Yield: 180 mg (38%); mp >250 °C.
1H NMR (400 MHz, DMSO-d6): δ = 5.04 (s, 2 H), 7.67–7.78 (m, 2 H),
7.93 (s, 1 H), 8.06 (d, J = 8.4 Hz, 1 H), 8.13 (dd, J = 8.4, 0.8 Hz, 2 H), 8.85
(d, J = 8.0 Hz, 1 H), 9.32 (s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 61.4, 123.2, 123.6, 124.5, 126.8,
127.4, 127.5, 128.5, 128.8, 128.9, 130.0, 134.1, 138.9, 167.7.
MS (ESI–): m/z (%) = 251 (100) [M – H]–.
Anal. Calcd for C16H12O3·0.25 H2O: C, 74.84; H, 4.91. Found: C, 74.82;
H, 4.83.
Methyl 9-(Bromomethyl)phenanthrene-3-carboxylate (33)
A flask containing 31 (1.17 g, 4.39 mmol) was briefly evacuated and
backfilled with argon. Anhydrous CH2Cl2 (100 mL) was added to the
flask by using a cannula and the resulting solution was cooled to 0 °C.
Phosphorus tribromide (1.65 mL, 17.56 mmol) was then added drop-
wise to the stirring solution. After complete addition, the reaction
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mixture was stirred at 0 °C for 30 min and then at r.t. until TLC analy-
sis confirmed complete conversion. After approximately 2 h, the reac-
tion mixture was again cooled to 0 °C and excess PBr3 was destroyed
by the dropwise addition of saturated NaHCO3 solution. The organic
layer was isolated, dried over MgSO4 and concentrated in vacuo to af-
ford an off-white solid, which was dissolved in Et2O (100 mL) and
washed successively with H2O (40 mL) and brine (40 mL). Drying over
MgSO4 followed by concentration in vacuo yielded 33.
Yield: 994 mg (69%); off-white solid; mp 135–139 °C.
1H NMR (300 MHz, CDCl3): δ = 4.03 (s, 3 H), 5.00 (s, 2 H), 7.73–7.78
(m, 2 H), 7.86 (s, 1 H), 7.90 (d, J = 8.4 Hz, 1 H), 8.20 (dd, J = 8.4, 1.8 Hz,
1 H), 8.22–8.27 (m, 1 H), 8.80–8.87 (m, 1 H), 9.39 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 31.8, 52.4, 123.5, 124.7, 125.1, 126.9,
127.4, 127.5, 128.1, 128.6, 128.8, 129.6, 130.3, 131.2, 134.0, 134.3,
167.2.
MS (CI+): m/z (%) = 328/330 (69/67) [M+], 249 (100).
Anal. Calcd for C17H13O2Br: C, 62.03; H, 3.98; Found: C, 62.31; H, 4.31.
Methyl 9-Methylphenanthrene-3-carboxylate (34)
Compound 33 (500 mg, 1.52 mmol) and Et3N (0.21 mL, 1.52 mmol)
were dissolved in dioxane (100 mL) and the resultant solution was
hydrogenated under 3 bar of hydrogen in the presence of 10 wt% pal-
ladium on activated carbon (50 mg) for 18 h. The reaction mixture
was then filtered through a Celite pad before being concentrated in
vacuo. The resultant solid was taken up in CH2Cl2 (50 mL) and washed
successively with aq 1 M HCl, H2O, and brine (25 mL each). Drying
over MgSO4 followed by concentration in vacuo afforded 34.
Yield: 344 mg (91%); off-white solid; mp 152–156 °C.
1H NMR (400 MHz, CDCl3): δ = 2.74 (s, 3 H), 4.02 (s, 3 H), 7.58 (s, 1 H),
7.65–7.75 (m, 2 H), 7.81 (d, J = 8.4 Hz, 1 H), 8.04–8.09 (m, 1 H), 8.43
(dd, J = 8.4, 1.6 Hz, 1 H), 8.78–8.83 (m, 1 H), 9.38 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 20.2, 52.2, 123.2, 124.7, 125.0, 126.2,
126.5, 126.8, 127.0, 127.0, 127.8, 129.0, 130.5, 132.1, 134.8, 135.5,
167.5.
HRMS (CI): m/z [M + H]+ calcd for C17H14O2: 251.1067; found:
251.1059.
9-Methylphenanthrene-3-carboxylic Acid (35)
By following General Procedure D, 34 (310 mg, 1.24 mmol), NaOH
(149 mg, 3.72 mmol) and dioxane afforded 35.
Yield: 199 mg (68%); off-white solid; mp >250 °C.
1H NMR (400 MHz, DMSO-d6): δ = 2.70 (s, 3 H), 7.69–7.78 (m, 3 H),
7.95 (d, J = 8.0 Hz, 1 H), 8.09 (dd, J = 8.0, 1.2 Hz, 1 H), 8.09–8.12 (m,
1 H), 8.82–8.86 (m, 1 H), 9.33 (s, 1 H), 13.01 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 19.7, 123.1, 124.3, 124.9, 125.9,
126.6, 127.2, 127.4, 128.0, 128.0, 128.3, 130.0, 131.5, 134.2, 135.2,
167.5.
MS (ESI–): m/z (%) = 235 (100) [M – H]–.
Anal. Calcd for C16H12O2: C, 81.34; H, 5.12. Found: C, 81.08; H, 5.40.
Methyl 9-(Isopropylaminomethyl)phenanthrene-3-carboxylate 
(36)
To a stirred mixture of 15 (750 mg, 2.84 mmol) and isopropylamine
(0.41 mL, 4.97 mmol) in anhydrous DCE (100 mL) was added sodium
triacetoxyborohydride (843 mg, 3.98 mmol). The resultant suspen-
sion was stirred at r.t. for 24 h. At this point TLC analysis indicated in-
complete conversion, so 12 drops of glacial acetic acid were added to
help catalyse the reaction. Stirring was continued for another 24 h,
then excess sodium triacetoxyborohydride was destroyed through
the dropwise addition of sat. aq NaHCO3 solution. EtOAc (40 mL) was
added and the organic phase was isolated, washed with brine (40
mL), dried over MgSO4 and concentrated in vacuo to give an orange
oil. Purification by flash chromatography (EtOAc then MeOH–EtOAc,
20%) afforded 36.
Yield: 779 mg (89%); golden coloured oil.
1H NMR (400 MHz, CDCl3): δ = 1.21 (d, J = 6.4 Hz, 6 H), 2.98–3.09 (m,
1 H), 4.02 (s, 3 H), 4.27 (s, 2 H), 7.65–7.74 (m, 2 H), 7.77 (s, 1 H), 7.88
(d, J = 8.4 Hz, 1 H), 8.18 (dd, J = 8.4, 1.6 Hz, 1 H), 8.80–8.84 (m, 1 H),
9.38 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 23.1, 49.1, 49.6, 52.3, 123.4, 124.3,
125.0, 125.5, 126.6, 126.9, 127.2, 127.5, 128.4, 129.4, 130.9, 130.9,
134.5, 137.3, 167.4.
HRMS (ESI): m/z [M]+ calcd for C20H21NO2: 305.1572; found:
305.1598.
9-(Isopropylaminomethyl)phenanthrene-3-carboxylic Acid (37)
To a stirring solution of 36 (740 mg, 2.41 mmol) in a mixture of diox-
ane (80 mL) and H2O (20 mL) was added dropwise a solution of NaOH
(289 mg, 7.23 mmol) dissolved in H2O (20 mL). The resultant mixture
was stirred at 75 °C until TLC analysis indicated complete hydrolysis.
After 4 h, the reaction mixture was cooled to r.t. and the dioxane was
removed in vacuo. The resultant aqueous solution was topped up
with H2O and acidified to pH 3 by using aq 1 M HCl. No product pre-
cipitated from solution, so the pH was readjusted to pH 7 by using aq
1 M NaOH and the solution was concentrated in vacuo to afford a
white solid. The crude product was dissolved in a minimum volume
of H2O and then absorbed onto AG-50 resin. The column was first
eluted with H2O until the pH of the aqueous fractions was neutral.
The product was then eluted with aq 1 M pyridine. Concentration of
the aqueous pyridine fractions in vacuo afforded 37 as a white solid,
which was azeotroped with water to remove any remaining pyridine
and then dried over P2O5.
Yield: 496 mg (70%); mp >250 °C.
1H NMR (400 MHz, D2O/NaOD, pH 11): δ = 0.99 (d, J = 6.4 Hz, 6 H),
2.61–2.72 (m, 1 H), 3.46 (s, 2 H), 6.99 (s, 1 H), 7.33–7.39 (m, 1 H),
7.42–7.52 (m, 3 H), 7.91 (dd, J = 8.0, 1.2 Hz, 1 H), 8.42 (d, J = 8.0 Hz,
1 H), 8.88 (s, 1 H).
13C NMR (125 MHz, D2O/NaOD, pH 11): δ = 21.2, 47.1, 47.9, 122.8,
123.1, 123.5, 124.5, 126.5, 126.6, 126.7, 127.8, 128.4, 129.5, 129.8,
132.4, 133.6, 134.1, 175.1.
HRMS (ESI): m/z [M – H]– calcd for C19H19NO2: 292.1343; found:
292.1352.
Anal. Calcd for C19H19NO2·0.55 H2O: C, 73.93; H, 6.76; N, 4.54. Found:
C, 73.90; H, 6.41; N, 4.45.
Methyl 9-(3-Methoxy-3-oxopropyl)phenanthrene-3-carboxylate 
(38)
Compound 14 (1.00 g, 3.12 mmol) was dissolved in EtOAc (150 mL)
with the aid of stirring and heating. The resultant solution was hydro-
genated under 3 bar of hydrogen in the presence of 10 wt% palladium
on activated carbon (100 mg) for 18 h. The reaction mixture was then
filtered through a Celite pad before being concentrated in vacuo to af-
ford a viscous pale-yellow oil. Purification by flash column chroma-
tography (EtOAc–hexane, 5 → 30%) afforded 38.
Yield: 536 mg (53%); light-coloured oil that solidified on standing;
mp 88–92 °C.
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1H NMR (400 MHz, CDCl3): δ = 2.84 (t, J = 8.0 Hz, 2 H), 3.48 (t, J =
8.0 Hz, 2 H), 3.72 (s, 3 H), 4.02 (s, 3 H), 7.63 (s, 1 H), 7.66–7.76 (m,
2 H), 7.85 (d, J = 8.0 Hz, 1 H), 8.10 (dd, J = 8.0, 1.6 Hz, 1 H), 8.15–8.21
(m, 1 H), 8.80–8.87 (m, 1 H), 9.39 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 28.5, 34.3, 51.8, 52.3, 123.6, 124.1,
125.0, 125.7, 126.6, 127.0, 127.3, 127.5, 128.2, 129.2, 130.9, 130.9,
134.6, 137.5, 167.4, 173.3.
HRMS (ESI): m/z [M + Na]+ calcd for C20H18O4: 345.1097; found:
345.1095.
Anal. Calcd for C20H18O4: C, 74.52; H, 5.63; found: C, 74.34; H, 6.04.
9-(2-Carboxyethyl)phenanthrene-3-carboxylic Acid (39)
By following General Procedure D, 38 (350 mg, 1.09 mmol), NaOH
(262 mg, 6.54 mmol) and THF afforded 39.
Yield: 156 mg (49%); off-white solid; mp >250 °C.
1H NMR (500 MHz, DMSO-d6): δ = 2.75 (t, J = 7.5 Hz, 2 H), 3.39 (t, J =
7.5 Hz, 2 H), 7.73–7.81 (m, 3 H), 8.01 (d, J = 8.0 Hz, 1 H), 8.12 (dd, J =
8.0, 1.5 Hz, 1 H), 8.17–8.22 (m, 1 H), 8.87–8.92 (m, 1 H), 9.33 (s, 1 H),
12.60 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 28.3, 34.4, 123.9, 124.8, 124.8,
125.7, 127.1, 127.7, 128.0, 128.8, 128.9, 128.9, 130.6, 131.0, 134.4,
138.2, 168.0, 174.2.
HRMS (ESI): m/z [M – H]– calcd for C18H14O4: 293.0819; found:
293.0821.
Anal. Calcd for C18H14O4·0.25 H2O: C, 72.35; H, 4.89; found: C, 72.36;
H, 5.02.
(9-Iodophenanthren-3-yl)methanol (40)
A stirred suspension of 1 (3.00 g, 8.62 mmol) and thionyl chloride (10
mL) in anhydrous dioxane (150 mL) was heated to reflux for 12 h. The
solution was then cooled to r.t. and the solvent was removed in vacuo.
The product was then dissolved in anhydrous THF and again concen-
trated in vacuo to remove any traces of thionyl chloride. The crude
acid chloride was then dissolved in anhydrous THF (100 mL) and the
resulting solution was cooled to 0 °C by using an ice-water bath.
NaBH4 (571 mg, 15.09 mmol) was then added portionwise over a pe-
riod of 10 min. After complete addition, the suspension was stirred at
0 °C for 30 min and then at r.t. for 12 h. Excess NaBH4 was destroyed
through the dropwise addition of H2O. The solvent was then removed
in vacuo and the resultant solid was suspended between EtOAc (100
mL) and H2O (100 mL). The aqueous layer was further extracted with
EtOAc (2 × 50 mL) and the organic layers were pooled, washed with
H2O (50 mL), brine (50 mL), and dried over MgSO4. Concentration in
vacuo gave a yellow solid. Purification by flash chromatography
(EtOAc–hexane, 10 → 40%) afforded 40.
Yield: 2.45 g (85%); yellow solid; mp 164–168 °C.
1H NMR (400 MHz, DMSO-d6): δ = 4.77 (s, 2 H), 5.44 (s, 1 H), 7.64 (d,
J = 8.0 Hz, 1 H), 7.72–7.81 (m, 2 H), 7.92 (d, J = 8.0 Hz, 1 H), 8.10–8.17
(m, 1 H), 8.59 (s, 1 H), 8.75 (s, 1 H), 8.78–8.83 (m, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 63.1, 97.9, 120.0, 123.2, 126.3,
127.5, 127.7, 128.1, 129.4, 130.1, 131.4, 131.5, 132.4, 138.0, 142.1.
HRMS (CI): m/z [M+] calcd for C15H11OI: 333.9855; found: 333.9862.
Anal. Calcd for C15H11OI: C, 53.92; H, 3.32. Found: C, 53.63; H, 3.54.
3-(Bromomethyl)-9-iodophenanthrene (41)
A flask containing 40 (2.43 g, 7.27 mmol) was briefly evacuated and
backfilled with argon. Anhydrous CH2Cl2 (200 mL) was added to the
flask by using a cannula and the resulting suspension was cooled to
0 °C. Phosphorus tribromide (2.73 mL, 29.08 mmol) was then added
dropwise to the stirred suspension. After complete addition, the solu-
tion was stirred at 0 °C for 30 min and then at r.t. until TLC analysis
confirmed complete conversion. After 1 h, the reaction mixture was
again cooled to 0 °C and excess PBr3 was destroyed by the dropwise
addition of saturated NaHCO3 solution. The organic layer was isolated,
dried over MgSO4 and concentrated in vacuo to afford a light-yellow
solid, which was dissolved in Et2O (100 mL) and washed successively
with H2O (40 mL) and brine (40 mL). Drying over MgSO4 followed by
concentration in vacuo gave 41.
Yield: 1.87 g (65%); pale-yellow solid; mp 124–128 °C.
1H NMR (500 MHz, CDCl3): δ = 4.75 (s, 2 H), 7.61 (dd, J = 8.0, 1.5 Hz,
1 H), 7.66–7.72 (m, 2 H), 7.74 (d, J = 8.0 Hz, 1 H), 8.20–8.23 (m, 1 H),
8.41 (s, 1 H), 8.59–8.62 (m, 1 H), 8.63 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 34.1, 99.7, 122.9, 123.3, 127.8, 128.1,
128.3, 128.4, 130.4, 130.5, 132.4, 132.8, 133.5, 136.7, 138.2.
HRMS (CI): m/z [M+] cald for C15H10BrI: 395.9011; found: 395.9012.
(9-Iodophenanthren-3-yl)acetonitrile (42)
Compound 41 (1.00 g, 2.52 mmol) was dissolved in anhydrous CH2Cl2
(75 mL) and stirred vigorously with a solution of NaCN (136 mg, 2.77
mmol) and tetra-n-butylammonium bromide (TBAB; 89 mg, 0.28
mmol) in H2O (75 mL). After 5 d, TLC analysis indicated complete con-
version. The organic layer was subsequently isolated and the aqueous
phase was extracted with CH2Cl2 (2 × 50 mL). The organic layers were
combined, dried over MgSO4 and concentrated in vacuo to afford a
brown oil. Purification by flash chromatography (EtOAc–hexane, 10 →
20%) gave 42.
Yield: 492 mg (57%); yellow solid; mp 141–145 °C.
1H NMR (500 MHz, CDCl3): δ = 4.00 (s, 2 H), 7.50 (dd, J = 8.5, 2.0 Hz,
1 H), 7.68–7.74 (m, 2 H), 7.77 (d, J = 8.5 Hz, 1 H), 8.20–8.25 (m, 1 H),
8.41 (s, 1 H), 8.59–8.63 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 24.2, 99.5, 122.1, 122.8, 126.6, 127.8,
128.3, 128.5, 128.7, 130.0, 130.6, 132.4, 132.4, 133.4, 137.9.
HRMS (ESI): m/z [M + Na]+ cald for C16H10NI: 365.9743; found:
365.9750.
(9-Iodophenanthren-3-yl)acetic Acid (43)
A stirred mixture of 42 (471 mg, 1.37 mmol), glacial acetic acid (15
mL), conc H2SO4 (3 mL) and H2O (3 mL) was heated to reflux until TLC
analysis indicated complete consumption of the starting material. Af-
ter 3 h, the mixture was cooled to r.t. and then diluted with H2O (100
mL). The aqueous mixture was extracted with Et2O (100 mL then
2 × 50 mL) and the organic layers were pooled and extracted with aq
1 M NaOH (3 × 50 mL). The alkaline phases were combined and acidi-
fied to pH 1 by using aq 2 M HCl. The aqueous solution was then ex-
tracted with Et2O (100 mL then 2 × 50 mL) and the organic layers
were pooled, dried over Na2SO4 and concentrated in vacuo to give 43.
Yield: 355 mg (72%); straw-coloured solid; mp 218–222 °C (dec).
1H NMR (400 MHz, DMSO-d6): δ = 3.87 (s, 2 H), 7.58 (dd, J = 8.0,
1.6 Hz, 1 H), 7.73–7.80 (m, 2 H), 7.91 (d, J = 8.0 Hz, 1 H), 8.11–8.16 (m,
1 H), 8.59 (s, 1 H), 8.73 (s, 1 H), 8.78–8.83 (m, 1 H), 12.48 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 40.9, 98.1, 123.3, 123.6, 127.4,
127.7, 128.2, 129.1, 129.5, 129.9, 131.2, 131.4, 132.4, 134.6, 137.9,
172.5.
HRMS (ESI): m/z [M – H]– calcd for C16H11O2I: 360.9735; found:
360.9731.
Anal. Calcd for C16H11O2I: C, 53.06; H, 3.06; Found: C, 52.85; H, 3.17.
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9-Iodophenanthrene-3-carboxylic Acid Benzylamide (44a)
A stirred suspension of 1 (1.00 g, 2.87 mmol) and thionyl chloride (5
mL) in anhydrous benzene (45 mL) was heated to reflux for 12 h. The
solution was then cooled to r.t. and the solvent was removed in vacuo.
The product was dissolved in a second aliquot of anhydrous benzene
and again concentrated in vacuo to remove traces of thionyl chloride.
The crude acid chloride was then dissolved in anhydrous dioxane (20
mL) and added dropwise to a rapidly stirring solution of benzylamine
(0.31 mL, 2.87 mmol) and Et3N (0.40 mL, 2.87 mmol) in anhydrous
dioxane (30 mL). After complete addition, the solution was stirred for
3 h at r.t. The solvent was then removed in vacuo and the resultant
solid was dissolved in a mixture of CH2Cl2 (100 mL) and H2O (40 mL).
The organic layer was isolated and washed successively with aq 1 M
HCl (2 × 30 mL), aq 1 M NaOH (2 × 30 mL), and H2O (40 mL). Drying
over MgSO4 followed by concentration in vacuo afforded 44a.
Yield: 459.2 mg (37%); off-white solid; mp 208–212 °C (dec).
1H NMR (400 MHz, DMSO-d6): δ = 4.61 (d, J = 6.0 Hz, 2 H), 7.23–7.24
(m, 1 H), 7.33–7.38 (m, 2 H), 7.38–7.43 (m, 2 H), 7.78–7.87 (m, 2 H),
8.05 (d, J = 8.4 Hz, 1 H), 8.16–8.20 (m, 1 H), 8.17 (dd, J = 8.4, 1.6 Hz,
1 H), 8.68 (s, 1 H), 8.91–8.95 (m, 1 H), 9.38 (s, 1 H), 9.42 (t, J = 6.0 Hz,
1 H).
13C NMR (100 MHz, DMSO-d6): δ = 42.8, 101.0, 122.0, 123.6, 126.1,
126.8, 127.3, 127.7, 128.1, 128.3, 128.6, 129.1, 130.2, 131.6, 132.6,
132.7, 134.0, 137.7, 139.5, 165.8.
HRMS (ESI): m/z [M + Na]+ calcd for C22H16NOI: 460.0169; found:
460.0164.
Anal. Calcd for C22H16NOI: C, 60.43; H, 3.69; N, 3.20. Found: C, 60.14;
H, 3.81; N, 2.85.
9-Iodophenanthrene-3-carboxylic Acid 2-Phenethyl Amide (44b)
The procedure was identical to that described for 44a with the excep-
tion that phenethylamine (0.36 mL, 2.87 mmol) was used.
Yield: 430.8 mg (33%); light-brown solid; mp 194–197 °C (dec).
1H NMR (400 MHz, DMSO-d6): δ = 2.94 (t, J = 7.6 Hz, 2 H), 3.56–3.63
(m, 2 H), 7.19–7.24 (m, 1 H), 7.28–7.34 (m, 4 H), 7.79–7.88 (m, 2 H),
8.03 (d, J = 8.4 Hz, 1 H), 8.09 (dd, J = 8.4, 1.6 Hz, 1 H), 8.16–8.20 (m,
1 H), 8.67 (s, 1 H), 8.88–8.92 (m, 1 H), 8.95 (t, J = 6.0 Hz, 1 H), 9.26 (s,
1 H).
13C NMR (100 MHz, DMSO-d6): δ = 35.1, 41.0, 100.7, 121.8, 123.3,
125.9, 127.5, 128.0, 128.2, 128.4, 128.5, 129.0, 130.2, 131.6, 132.5,
132.9, 133.8, 137.7, 139.4, 165.8.
HRMS (ESI): m/z [M + Na]+ calcd for C23H18NOI: 474.0325; found:
474.0318.
Anal. Calcd for C23H18NOI·0.39 H2O: C, 60.27; H, 4.13; N, 3.06. Found:
C, 60.27; H, 4.40; N, 2.96.
tert-Butyl [(9-Iodophenanthrene-3-carbonyl)amino]acetate (45)
Initial synthesis and purification of the acid chloride was as described
for 44a with the exception that 1 (600 mg, 1.72 mmol), thionyl chlo-
ride (3 mL) and anhydrous benzene (45 mL) were used. The crude
acid chloride was then dissolved in anhydrous dioxane (20 mL) and
added dropwise to a rapidly stirring suspension of glycine tert-butyl
ester hydrochloride (301.7 mg, 1.80 mmol) and Et3N (0.48 mL, 3.44
mmol) in anhydrous dioxane (30 mL), which had been prestirred for
30 min. After complete addition, the mixture was stirred at r.t. for 3 h.
The dioxane was then removed in vacuo and the resulting solid was
dissolved in a mixture of CH2Cl2 (100 mL) and H2O (30 mL). The or-
ganic layer was isolated and washed successively with aq 1 M HCl
(2 × 30 mL), aq 1 M NaOH (2 × 30 mL), H2O (30 mL) and brine (30 mL).
Subsequent drying over MgSO4 followed by concentration in vacuo af-
forded 45.
Yield: 576.3 mg (73%); orange/yellow oil.
1H NMR (400 MHz, CDCl3): δ = 1.55 (s, 9 H), 4.24 (d, J = 4.8 Hz, 2 H),
7.05 (t, J = 4.8 Hz, 1 H), 7.66–7.74 (m, 3 H), 7.89 (dd, J = 8.4, 1.6 Hz,
1 H), 8.14–8.20 (m, 1 H), 8.36 (s, 1 H), 8.58–8.64 (m, 1 H), 9.08 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 28.1, 42.7, 82.7, 101.4, 122.6, 123.0,
124.6, 127.8, 128.0, 128.3, 129.9, 130.4, 131.9, 132.2, 133.3, 134.5,
137.8, 167.1, 169.5.
HRMS (ESI): m/z [M + Na]+ calcd for C21H20NO3I: 484.0380; found:
484.0371.
[(9-Iodophenanthrene-3-carbonyl)amino]acetic Acid (46)
To a stirred solution of 45 (565.9 mg, 1.23 mmol) and m-dimethoxy-
benzene (0.81 mL, 6.15 mmol) in CH2Cl2 (30 mL) was added dropwise
TFA (4.57 mL, 61.5 mmol). The resulting mixture was stirred at r.t. un-
til TLC analysis confirmed complete deprotection. The solvent was
then removed in vacuo and the resulting solid was azeotroped with
toluene (3 × 30 mL) to remove traces of TFA. The solid was then sus-
pended in Et2O (30 mL) and stirred for 10 min before being filtered off
and washed thoroughly with Et2O. Air-drying subsequently afforded
46.
Yield: 346.4 mg (70%); light-yellow solid; mp 241–244 °C (dec).
1H NMR (400 MHz, DMSO-d6): δ = 4.06 (d, J = 5.6 Hz, 2 H), 7.79–7.88
(m, 2 H), 8.05 (d, J = 8.4 Hz, 1 H), 8.14 (dd, J = 8.4, 1.6 Hz, 1 H), 8.16–
8.20 (m, 1 H), 8.69 (s, 1 H), 8.90–8.94 (m, 1 H), 9.26 (t, J = 5.6 Hz, 1 H),
9.36 (s, 1 H), 12.71 (br s, 1 H).
13C NMR (100 MHz, DMSO-d6): δ = 41.3, 101.2, 122.1, 123.5, 126.0,
127.8, 128.2, 128.7, 129.1, 130.2, 131.7, 132.1, 132.6, 134.1, 137.7,
166.1, 171.3.
HRMS (ESI): m/z [M – H]– calcd for C17H12NO3I: 403.9789; found:
403.9803.
Anal. Calcd for C17H12NO3I: C, 50.39; H, 2.99; N, 3.46. Found: C, 50.73;
H, 2.93; N, 3.11.
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